Intellectual Disability, X-linked, Syndromic 33

Mendelian MONDO:0010500 Pathograph 40 Show in embeddings browser X-linked syndromic intellectual disability multiple congenital anomalies/dysmorphic syndrome-intellectual disability

Intellectual disability, X-linked, syndromic 33 (MRXS33; TAF1 intellectual disability syndrome) is an X-linked neurodevelopmental disorder of affected males caused by germline variants in TAF1, which encodes the largest subunit of the general transcription factor TFIID. Affected boys present early with generalized hypotonia, global developmental delay, and characteristic facial dysmorphology, evolving into intellectual disability and/or autism spectrum disorder; a broadened allelic series adds brain morphological abnormalities, seizures, hearing loss, and heart malformations. Reported disease alleles are predominantly missense, with a start-loss variant, a splice-site variant, and two locus duplications also described. Complete TAF1 loss is embryonic-lethal in mouse and zebrafish, and no hemizygous null alleles of the canonical coding isoform are seen in population databases, so the disorder is best understood as a hypomorphic, dosage- and activity-sensitive lesion of the RNA polymerase II preinitiation machinery rather than a null. Two families with large Xq13.1 duplications involving TAF1 overlap the missense phenotype but additionally show severe progressive neurodegeneration. MRXS33 is allelic to, and clinically distinct from, X-linked dystonia-parkinsonism (XDP, curated separately in this knowledge base). XDP arises from a Filipino founder SINE-VNTR-Alu retrotransposon insertion in intron 32 of TAF1 and is an adult-onset neurodegenerative movement disorder with neostriatal neuronal loss; MRXS33 arises from coding missense variants (or locus duplication) and is a congenital neurodevelopmental syndrome. The two share a gene and a broad theme of TAF1 transcriptional dysregulation, but differ in lesion class, age of onset, neuroanatomical target, and clinical syndrome.

Ask OpenScientist

Ask a research question about Intellectual Disability, X-linked, Syndromic 33. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
9
Pathophys.
28
Phenotypes
2
Hypotheses
1
Gaps
40
Pathograph
1
Genes
4
Variants
2
Medical Actions
2
Differentials
3
Models
2
References
1
Deep Research
👪

Inheritance

1
X-linked recessive HP:0001419
TAF1 maps to Xq13.1 and the syndrome manifests in hemizygous males, with variants arising de novo or inherited from an unaffected carrier mother. Heterozygous carrier females are typically asymptomatic in association with completely skewed X-chromosome inactivation toward the non-mutant chromosome, although symptomatic females carrying TAF1 variants have also been reported.
X-linked recessive inheritance
Show evidence (5 references)
PMID:26637982 SUPPORT Human Clinical
"We describe an X-linked genetic syndrome associated with mutations in TAF1 and manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals."
The original description establishes X-linked transmission with disease manifest in males.
PMID:31341187 SUPPORT Human Clinical
"All affected males presented with intellectual disability and dysmorphic features, while heterozygous females were asymptomatic and had completely skewed X-chromosome inactivation."
A five-generation pedigree showing male-limited expression with skewed XCI in asymptomatic carrier females, the pattern that makes the inheritance recessive in practice.
PMID:26637982 SUPPORT Human Clinical
"Simultaneous studies using diverse strategies led to the identification of nine families with overlapping clinical presentations and affected by de novo or maternally inherited single-nucleotide changes."
Documents both de novo and maternally inherited origins of the causal single-nucleotide changes.
+ 2 more references
◈

Mechanistic Hypotheses

2
Reduced RAP74 phosphorylation as the route from TAF1 variant to transcriptional dysfunction
rap74_phosphorylation_route EMERGING
Evidence balance 1 support 1 refute
Patient lymphoblasts carrying two independent pathogenic TAF1 variants show reduced phosphorylation of RAP74. The authors advance this as a potential mechanism connecting the variants to transcriptional dysfunction. Two things keep it a hypothesis rather than a curated step. No study has shown the phosphorylation deficit is necessary or sufficient for the neurodevelopmental phenotype; and the mechanism the authors propose depends on TAF1 itself being the kinase, an activity a 2024 review reports could not be confirmed in recent TFIID/TAF1 studies, with much of the original work retracted. The measured phosphorylation change stands; its attribution to a TAF1 kinase activity does not.
Pathograph links
Reduced RAP74 Phosphorylation in Patient Cells -> TFIID-Dependent Transcription Dysfunction INDIRECT UNKNOWN INTERMEDIATES RAP74 is a subunit of TFIIF, a general transcription factor that acts in preinitiation complex assembly as well as elongation, so reduced phosphorylation is proposed to feed into the general transcription defect. The cited study frames this as a potential mechanism rather than a demonstrated route.
Show evidence (2 references)
PMID:42548218 SUPPORT In Vitro
"This study expands the phenotypic spectrum of TAF1-related XLID and implicates reduced RAP74 phosphorylation as a potential mechanism."
The source's own framing as a potential mechanism is what this hypothesis group records.
PMID:39323550 REFUTE Other
"These studies could not be reproduced by others and much of the related work by Sauer et al. has been retracted"
Undercuts the kinase premise the proposed mechanism rests on, which is why this group is EMERGING rather than a curated causal step.
Cerebellar Purkinje cell loss as the substrate of the motor phenotype
cerebellar_purkinje_route EMERGING
Evidence balance 2 support
A CRISPR-edited rat model shows that TAF1 deletion in the developing brain causes Purkinje cell hypoplasia and loss with reduced CaV3.1 expression, and that pharmacological enhancement of T-type calcium channels rescues both the cells and the behavior. Whether cerebellar Purkinje pathology is the substrate of gait disturbance in human MRXS33 is untested: no human neuropathology has been reported, and brain MRI is normal in some affected males.
Pathograph links
Impaired Neuronal Differentiation and Neurodevelopment -> Cerebellar Purkinje Cell Loss INDIRECT UNKNOWN INTERMEDIATES TAF1 deletion in the developing rat brain produces Purkinje cell hypoplasia and loss. Whether the same cellular route operates in human MRXS33 is not established.
Cerebellar Purkinje Cell Loss -> Cerebellar hypoplasia INDIRECT UNKNOWN INTERMEDIATES Purkinje cell hypoplasia and loss in the TAF1-edited rat is the model-derived candidate substrate for the cerebellar hypoplasia reported in a TAF1 proband. No human neuropathology exists to confirm that the human imaging finding reflects this cellular lesion, and brain MRI is normal in affected males from another pedigree.
Cerebellar Purkinje Cell Loss -> Gait disturbance INDIRECT UNKNOWN INTERMEDIATES Cerebellar Purkinje pathology is the model-derived candidate substrate for the motor and gait phenotype seen in patients. The evidence for this link is entirely from the rat model.
Show evidence (2 references)
PMID:31344492 SUPPORT Model Organism
"Abnormal motor symptoms in TAF1-edited rats were associated with irregular cerebellar output caused by changes in the intrinsic activity of the Purkinje cells due to loss of pre-synaptic CaV3.1."
Supplies the model-level mechanism the hypothesis proposes to extend to humans.
PMID:31344492 SUPPORT Other
"How these mutations cause dysmorphology, hypotonia, intellectual and motor defects is unknown."
The same paper states that the route from mutation to motor defect is unknown, which is why this remains a hypothesis rather than a curated causal chain.
?

Discussions and Knowledge Gaps

1
Every TAF1 animal model uses a null or somatic-deletion lesion, while human MRXS33 is caused by germline hypomorphic missense variants. Does any existing model report on the mechanism of the human missense disease?
HUMAN MODEL MISMATCH taf1_models_are_null_human_disease_is_hypomorphic
Attached to
pathophysiology#TAF1 Hypomorphic Missense Variants pathophysiology#Cerebellar Purkinje Cell Loss
The mismatch is structural, not incidental. Complete TAF1 loss is embryonically lethal in both mouse and zebrafish, so the genotype that corresponds to an affected human male cannot be studied in those systems at all; the rat model circumvents lethality only by deleting TAF1 somatically in the postnatal brain, which is a different lesion in a different developmental window. Consequently the cerebellar Purkinje pathology that the rat model contributes — the entry's only cellular account of the motor phenotype — rests on a lesion class the human disease does not have, and no human neuropathology exists to check it against. Brain MRI is reported normal in at least one affected male, which is at least consistent with the cerebellar route not being universal.
Show evidence (2 references)
PMID:31344492 SUPPORT Model Organism
"Mouse models which have embryonically targeted TAF1 have failed, possibly due to TAF1 being essential for viability, preferentially expressed in early brain development, and intolerant of mutation."
States why germline mammalian models of TAF1 are unavailable, which is the origin of the mismatch.
PMID:38804708 SUPPORT Model Organism
"We discovered that Taf1 deletion in male mice was embryonically lethal, which may explain why no null variants have been identified in humans."
Confirms the lethality of the null genotype in the mammalian model, closing off the direct comparison to affected human males.
⚙

Pathophysiology

9
TAF1 Hypomorphic Missense Variants
Germline missense variants across the TAF1 coding sequence are the predominant disease lesion. Reported alleles are almost exclusively missense, and hemizygous or homozygous loss-of-function alleles are absent from population databases, which together with embryonic lethality of null alleles in mouse and zebrafish indicates that surviving disease alleles are hypomorphic rather than null.
TAF1 hgnc:11535 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves TAF1 (hgnc:11535). hgnc:11535 is a gene from the HUGO Gene Nomenclature Committee.
Animal models
Taf1 knockout mouse Mouse fails to recapitulate A complete null does not model the human hypomorphic disease lesion: male nulls die in utero rather than developing a neurodevelopmental syndrome, and heterozygous females escape the lesion through skewed X inactivation. The link is pointed at the lesion node rather than at the downstream transcription node because a null unquestionably perturbs TFIID-dependent transcription — what it fails to reproduce is the partial-function allele the human disease actually carries.
taf1 knockout zebrafish Zebrafish measures The model provides the organismal evidence that complete TAF1 loss is not viable, which is the basis for interpreting human disease alleles as hypomorphic rather than null.
Downstream
Loss of TAF1 Bromodomain Repression in Cardiogenesis Damaging missense variants falling in the C-terminal bromodomain abolish its repressive function directly, shown by mutational analysis of patient-derived variants.
Reduced RAP74 Phosphorylation in Patient Cells Patient-derived lymphoblasts carrying the causal variants show reduced RAP74 phosphorylation. The variant-to-phosphorylation observation is direct; the mechanism connecting them is not settled (see the node).
TFIID-Dependent Transcription Dysfunction TAF1 is the largest subunit of TFIID and directs assembly of the RNA polymerase II preinitiation complex, so a hypomorphic TAF1 is presumed to degrade that function. No cited study measures preinitiation complex assembly or TFIID function in patient material, so this edge rests on TAF1's known normal role rather than on a measured defect.
Show evidence (2 references)
PMID:31646703 SUPPORT Human Clinical
"To date, only missense variants have been found; the lack of hemi- and homozygous loss-of-function variants in the protein coding part of the canonical TAF1 isoform in human population databases suggests that the complete loss of TAF1 may be embryonic-lethal."
Establishes both the missense-only allelic spectrum and the inference that complete loss is not compatible with life, which is what makes the disease alleles hypomorphic.
PMID:26637982 SUPPORT Human Clinical
"Our results suggest that mutations in TAF1 play a critical role in the development of this X-linked ID syndrome."
The original series' conclusion that TAF1 mutation is causal for the syndrome.
Loss of TAF1 Bromodomain Repression in Cardiogenesis
TAF1's C-terminal bromodomain exerts a repressive role during cardiogenesis. Damaging bromodomain missense variants taken from congenital heart disease patients abrogate that repression, and a selective chemical inhibitor of the TAF1 bromodomain reproduces the same effect - it was recovered in an unbiased screen as an activator of atrial and ventricular fetal myosins during pluripotent stem cell differentiation. This is the entry's only mechanism-level account of the cardiac phenotype, and it is specific to the bromodomain variant class rather than to TAF1 variants generally.
Downstream
Congenital heart malformation Derepression of TAF1 bromodomain targets during cardiogenesis is the proposed route to the congenital heart malformations seen in patients carrying damaging bromodomain variants. The work is done in stem-cell differentiation and in vitro mutational analysis, not in patient hearts, so the intervening steps to a formed cardiac malformation are not established.
Show evidence (2 references)
PMID:36958711 SUPPORT In Vitro
"Damaging TAF1 missense variants from CHD patients were studied by mutational analysis of the TAF1 bromodomain, demonstrating a repressive role of TAF1 that can be abrogated by the introduction of damaging bromodomain variants or chemical TAF1 bromodomain inhibition."
Establishes both the repressive bromodomain function and its abrogation by patient-derived damaging variants, which is the node's central claim.
PMID:36958711 SUPPORT In Vitro
"TAF1 bromodomain inhibitors were tested for their effects on stem cell viability and cardiomyocyte differentiation, implicating a role for TAF1 in cardiogenesis."
Independent pharmacological arm implicating TAF1 in cardiomyocyte differentiation, corroborating the genetic result.
TAF1 Locus Duplication
A second, distinct initiating lesion: large duplications at Xq13.1 encompassing TAF1 and neighboring genes. These families overlap the missense phenotype but add severe progressive neurodegeneration, so the duplication is modeled as its own trigger rather than as a variant class of the missense lesion.
TAF1 hgnc:11535 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves TAF1 (hgnc:11535). hgnc:11535 is a gene from the HUGO Gene Nomenclature Committee.
Downstream
Progressive neurodegeneration in TAF1 duplication The duplication families show severe progressive neurodegeneration, but the duplications span genes beyond TAF1 and no intervening mechanism has been established, so the route from duplication to neurodegeneration is recorded as unresolved.
TFIID-Dependent Transcription Dysfunction Increased TAF1 dosage is presumed to perturb the same TFIID-dependent transcriptional function that the missense alleles impair, but no direct measurement of TFIID function in duplication carriers has been reported.
Show evidence (1 reference)
PMID:26637982 SUPPORT Human Clinical
"Two additional families harboring large duplications involving TAF1 were also found to share phenotypic overlap with the probands harboring single-nucleotide changes, but they also demonstrated a severe neurodegeneration phenotype."
Identifies the duplication lesion and its distinct additional phenotype.
Reduced RAP74 Phosphorylation in Patient Cells
Lymphoblasts from probands carrying two independent pathogenic TAF1 variants show reduced phosphorylation of RNA polymerase II-associated protein 74 (RAP74). The curated observation here is that measured reduction in RAP74 phosphorylation, not the identity of the responsible kinase. PMID:42548218 attributes the activity to TAF1's own N- and C-terminal serine/threonine kinase domains, but a 2024 TAF1 review reports that the enzymatic activities historically attributed to TAF1 — kinase among them — could not be confirmed in recent TFIID/TAF1 studies and that much of the underlying work has been retracted. This node therefore does not bind a TAF1 kinase molecular function, and the route onward to transcriptional dysfunction is hypothesis-scoped.
Reduced RAP74 phosphorylation as the route from TAF1 variant to transcriptional dysfunction
Downstream
TFIID-Dependent Transcription Dysfunction RAP74 is a subunit of TFIIF, a general transcription factor that acts in preinitiation complex assembly as well as elongation, so reduced phosphorylation is proposed to feed into the general transcription defect. The cited study frames this as a potential mechanism rather than a demonstrated route. Reduced RAP74 phosphorylation as the route from TAF1 variant to transcriptional dysfunction
Show evidence (3 references)
PMID:42548218 SUPPORT Other
"The N- and C-terminal domains of TAF1 are known to possess a serine/threonine kinase activity that selectively phosphorylates RNA polymerase II-associated protein 74 (RAP74)."
The source of the attributed TAF1 kinase activity, recorded here as the claim this paper makes rather than as established fact - see the REFUTE item below.
PMID:39323550 REFUTE Other
"several enzymatic activities have been attributed to TAF1 in the past, which could not be confirmed in recent TFIID and/or TAF1 studies. These include kinase, histone acetylation and ubiquitination activities"
Contradicts the premise that TAF1 itself is the kinase acting on RAP74, which is why this node curates the measured phosphorylation change rather than a TAF1 kinase activity.
PMID:42548218 SUPPORT In Vitro
"This study expands the phenotypic spectrum of TAF1-related XLID and implicates reduced RAP74 phosphorylation as a potential mechanism."
States the authors' mechanistic inference, while its hedged wording is why this node is not treated as an established step.
TFIID-Dependent Transcription Dysfunction
TAF1 is the largest subunit of TFIID, which with TATA-binding protein and the other TBP-associated factors nucleates the RNA polymerase II preinitiation complex at essentially all pol II promoters. A TAF1 lesion therefore perturbs a general transcription function rather than a single target pathway. The node is tagged DYSREGULATED rather than DECREASED because it has two upstream lesions pushing in opposite directions — hypomorphic missense alleles reducing TAF1 function and Xq13.1 duplications increasing TAF1 dosage — and because no study has measured preinitiation complex assembly in patient material in either direction.
RNA polymerase II preinitiation complex assembly GO:0051123 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated RNA polymerase II preinitiation complex assembly (GO:0051123). GO:0051123 is a biological process from the Gene Ontology. ↕ DYSREGULATED
Downstream
Impaired Craniofacial Development The general transcription defect is presumed to disrupt the craniofacial developmental program, the route supported by taf1/taf5 zebrafish phenocopy rather than by any measurement in human craniofacial tissue.
Dysregulated Neurodevelopmental Transcriptional Program Downstream gene sets are shifted in TAF1-lesioned material — genes regulated by E-box proteins in a patient family, genes associated with neurodevelopmental processes in a taf1-null zebrafish. Neither study measured TFIID function itself, so attributing the transcriptional shift specifically to impaired TFIID is an inference rather than a measured link; the patient study reports the signature as associated with the phenotype.
Show evidence (3 references)
PMID:31646703 SUPPORT Other
"TAF1 encodes the largest subunit of the basal transcription factor II D (TFIID), which directs the assembly of the pol II preinitiation complex (Papai, Weil, & Schultz, 2011) and is likely required for all pol II gene promoters"
Establishes TAF1's role in preinitiation complex assembly and the generality of that requirement.
PMID:39323550 SUPPORT Other
"TAF1 is best known for being part of a protein complex with TBP and other TAFs, forming the basal transcription factor IID (TFIID), which is an essential component of the RNA pol II initiation complex"
A dedicated TAF1 review confirming the same molecular role.
PMID:29545534 SUPPORT In Vitro
"Mutation of the TAF1 zinc knuckle with defects in DNA binding compromises promoter occupancy of TFIID, which leads to a decrease in transcription and cell viability."
Experimental demonstration that a TAF1 point mutation degrading DNA binding reduces TFIID promoter occupancy and transcription - the closest direct evidence that a TAF1 coding lesion impairs this node's function.
Impaired Craniofacial Development
Loss of TAF/TFIID function disrupts craniofacial development. In zebrafish, taf5 nonsense mutation produces craniofacial hypoplasia alongside cardiac defects, and CRISPR editing shows the same defects are phenocopied by taf1 mutation; craniofacial hypoplasia is part of the shared human TAFopathy phenotype. This node is the developmental substrate for the recognizable facial gestalt, and its direct evidence is from model organisms.
craniofacial region UBERON:0007811 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in craniofacial region, annotated with craniocervical region (UBERON:0007811). UBERON:0007811 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Characteristic facial dysmorphism Disrupted craniofacial development is the presumed substrate for the recognizable facial gestalt. The developmental evidence is from zebrafish; no study traces the human facial features to a specific craniofacial developmental step.
High palate A high palate is a craniofacial structural finding and is attached to the craniofacial developmental node on the same model-derived basis as the rest of the gestalt.
Show evidence (2 references)
PMID:37746814 SUPPORT Model Organism
"CRISPR/CAS9 mediated gene editing revealed that these defects where phenocopied by mutations in taf1 and taf5."
Establishes that taf1 mutation specifically reproduces the craniofacial and cardiac defect set in a whole organism.
PMID:37746814 SUPPORT Other
"Pathogenic variants in components of TATA-binding protein associated factors (TAFs) have recently been identified in a subset of patients with intellectual disability, craniofacial hypoplasia, and congenital heart disease."
Places craniofacial involvement in the human TAFopathy phenotype. Graded OTHER as the study's background summary of others' human findings.
Dysregulated Neurodevelopmental Transcriptional Program
The transcriptional consequence of impaired TFIID function is preferentially felt in neurodevelopmental gene sets. Patient RNA-seq shows downregulation of E-box-regulated genes; taf1-null zebrafish transcriptomes are enriched for neurodevelopmental genes; and TAF1-deficient neuronal cells show differential expression of neuronal ion channel genes.
regulation of transcription by RNA polymerase II GO:0006357 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated regulation of transcription by RNA polymerase II (GO:0006357). GO:0006357 is a biological process from the Gene Ontology. ↕ DYSREGULATED
Animal models
taf1 knockout zebrafish Zebrafish perturbs Complete loss of taf1 perturbs the transcriptional program and reveals enrichment for neurodevelopmental genes, supporting the specificity of the transcriptional lesion for neurodevelopment.
Downstream
Impaired Neuronal Differentiation and Neurodevelopment TAF1-variant neuronal cells show both a shifted expression program and impaired differentiation and proliferation, but the two were measured separately and the source states the differentiation effect as a possibility rather than a demonstrated consequence of the expression change.
Show evidence (2 references)
PMID:26637982 SUPPORT Human Clinical
"the phenotype is associated with downregulation of a set of genes notably enriched with genes regulated by E-box proteins"
Names the specific transcriptional signature observed in a patient family.
PMID:32714589 SUPPORT In Vitro
"Our results showed that neuronal ion channel genes were differentially expressed between TAF1 deletion and TAF1 variant p.Ser1600Gly cells, when compared with their respective controls, and that the TAF1 variant may impair neuronal differentiation and cell proliferation."
Shows in a neuronal cell model that both TAF1 deletion and the patient variant shift neuronal gene expression.
Impaired Neuronal Differentiation and Neurodevelopment
Neuronal differentiation and proliferation are impaired in TAF1-variant neuronal cells, and intact taf1 is required for embryonic development with knockout transcriptomes enriched for neurodevelopmental processes. This is the cellular step through which the transcriptional lesion becomes a neurodevelopmental syndrome.
Cerebellar Purkinje cell loss as the substrate of the motor phenotype
neuron differentiation GO:0030182 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased neuron differentiation (GO:0030182). GO:0030182 is a biological process from the Gene Ontology. ↓ DECREASED
Downstream
Global developmental delay Impaired neurodevelopment is the presumed route to the clinical developmental delay, but no study traces the intervening steps in humans.
Intellectual disability Intellectual disability is the cognitive endpoint of the impaired neurodevelopmental program. The specific neural substrate is not established.
Generalized hypotonia Hypotonia is one of the earliest manifestations of the impaired neurodevelopmental program. No study traces it to a specific neural or neuromuscular substrate in this disorder.
Delayed speech and language development Speech and language delay follows the same impaired neurodevelopmental program as the global delay, without an established specific substrate.
Autism spectrum disorder Autism spectrum diagnoses arise from the same impaired neurodevelopmental program that yields the cognitive phenotype. No study identifies the circuit-level substrate.
Abnormal brain morphology Structural brain abnormalities are a consequence of the impaired neurodevelopmental program. They are not universal - brain MRI is normal in some affected males.
Seizure Seizures are attached to the neurodevelopmental node as a consequence of disordered neuronal development. A candidate contributory mechanism is the altered expression of neuronal ion channel genes seen in TAF1-variant cells, but that link has not been tested against the clinical seizure phenotype.
Oral-pharyngeal dysphagia Oral-pharyngeal dysphagia is grouped with the neurodevelopmental and hypotonic features on which it plausibly depends. No study establishes the route.
Cerebellar Purkinje Cell Loss TAF1 deletion in the developing rat brain produces Purkinje cell hypoplasia and loss. Whether the same cellular route operates in human MRXS33 is not established. Cerebellar Purkinje cell loss as the substrate of the motor phenotype
Show evidence (2 references)
PMID:31341187 SUPPORT Model Organism
"In conclusion, we propose that functional TAF1 is essential for embryonic development and specifically neurodevelopmental processes."
The zebrafish knockout study's conclusion that TAF1 function is specifically required for neurodevelopment.
PMID:32714589 SUPPORT In Vitro
"further extends our knowledge of a potential link between TAF1 deficiency and defects in neuronal cell function"
States the link between TAF1 deficiency and neuronal cell dysfunction at the hedging level the source supports.
Cerebellar Purkinje Cell Loss
In a CRISPR/Cas9 TAF1-edited rat model, TAF1 deletion causes Purkinje cell hypoplasia and loss with reduced CaV3.1 T-type calcium channel expression, and abnormal motor symptoms track with the resulting irregular cerebellar output. This node is model-derived: no human neuropathology has been reported for MRXS33.
Cerebellar Purkinje cell loss as the substrate of the motor phenotype
cerebellar Purkinje cell CL:0000121 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cerebellar Purkinje cell, annotated with Purkinje cell (CL:0000121). CL:0000121 is a cell type from the Cell Ontology.
cerebellum UBERON:0002037 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebellum (UBERON:0002037). UBERON:0002037 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
CRISPR/Cas9 TAF1-edited rat Rat recapitulates TAF1 deletion in the developing rat brain produces Purkinje cell hypoplasia and loss with reduced CaV3.1 expression and associated motor deficits — the observations that define this node.
Downstream
Cerebellar hypoplasia Purkinje cell hypoplasia and loss in the TAF1-edited rat is the model-derived candidate substrate for the cerebellar hypoplasia reported in a TAF1 proband. No human neuropathology exists to confirm that the human imaging finding reflects this cellular lesion, and brain MRI is normal in affected males from another pedigree. Cerebellar Purkinje cell loss as the substrate of the motor phenotype
Gait disturbance Cerebellar Purkinje pathology is the model-derived candidate substrate for the motor and gait phenotype seen in patients. The evidence for this link is entirely from the rat model. Cerebellar Purkinje cell loss as the substrate of the motor phenotype
Show evidence (2 references)
PMID:31344492 SUPPORT Model Organism
"Deletion of TAF1 lead to a hypoplasia and loss of the Purkinje cells."
Reports the Purkinje cell hypoplasia and loss that defines this node.
PMID:31344492 SUPPORT Model Organism
"Abnormal motor symptoms in TAF1-edited rats were associated with irregular cerebellar output caused by changes in the intrinsic activity of the Purkinje cells due to loss of pre-synaptic CaV3.1."
Connects the Purkinje pathology to a motor readout through a specified channel mechanism in the model.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Intellectual Disability, X-linked, Syndromic 33 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

28
Cardiovascular 1
Congenital heart malformation OCCASIONAL Abnormal heart morphology HP:0001627 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal heart morphology (HP:0001627). HP:0001627 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:31646703 SUPPORT Human Clinical
"prominent among previously unreported effects were brain morphological abnormalities, seizures, hearing loss, and heart malformations"
Identifies heart malformations as part of the broadened phenotypic spectrum.
PMID:37746814 SUPPORT Other
"Pathogenic variants in components of TATA-binding protein associated factors (TAFs) have recently been identified in a subset of patients with intellectual disability, craniofacial hypoplasia, and congenital heart disease."
Places congenital heart disease in the shared TAFopathy phenotype of which TAF1 disease is a member. This is a background statement in a zebrafish study summarizing others' human findings, hence OTHER rather than HUMAN_CLINICAL.
Digestive 1
Oral-pharyngeal dysphagia HP:0200136 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Oral-pharyngeal dysphagia (HP:0200136). HP:0200136 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"revealed additional clinical features, such as oral-pharyngeal dysphagia, a high palate, generalized muscle hypotonia, joint hypermobility, and kyphosis"
Documents oral-pharyngeal dysphagia on detailed assessment of affected males.
Ear 3
Low-set ears HP:0000369 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Low-set ears (HP:0000369). HP:0000369 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"who presented with a long face, pointed chin, prominent forehead, long philtrum, prominent supraorbital ridge, deep-set eyes, and low-set, protruding, large ears"
Documents low-set ears in all six affected males of the pedigree.
Protruding ear HP:0000411 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Protruding ear (HP:0000411). HP:0000411 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31646703 SUPPORT Human Clinical
"many patients were noted to have prominent supraorbital ridges, low-set and protruding ears, and a prominent (sometimes anteverted) nasal tip"
Reports protruding ears among the recurrent facial features.
Hearing impairment OCCASIONAL HP:0000365 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hearing impairment (HP:0000365). HP:0000365 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31646703 SUPPORT Human Clinical
"Other less common features included seizures, hearing loss, strabismus, and cardiac and genitourinary anomalies."
Lists hearing loss among the less common features of the syndrome.
Eye 1
Strabismus OCCASIONAL HP:0000486 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Strabismus (HP:0000486). HP:0000486 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31646703 SUPPORT Human Clinical
"Other less common features included seizures, hearing loss, strabismus, and cardiac and genitourinary anomalies."
Lists strabismus among the less common features.
Genitourinary 1
Genitourinary anomaly OCCASIONAL Abnormality of the genitourinary system HP:0000119 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormality of the genitourinary system (HP:0000119). HP:0000119 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31646703 SUPPORT Human Clinical
"Other less common features included seizures, hearing loss, strabismus, and cardiac and genitourinary anomalies."
Lists genitourinary anomalies among the less common features, supporting the OCCASIONAL band.
Head and Neck 8
Characteristic facial dysmorphism Abnormal facial shape HP:0001999 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal facial shape (HP:0001999). HP:0001999 is a phenotype from the Human Phenotype Ontology.
Sequelae: Prominent supraorbital ridges Low-set ears Protruding ear Long philtrum Long face Pointed chin Prominent forehead Short neck
Show evidence (2 references)
PMID:26637982 SUPPORT Human Clinical
"manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features"
Establishes characteristic facial dysmorphology as a defining feature.
PMID:31646703 SUPPORT Human Clinical
"Dysmorphic facial features, which are particularly prone to observer bias, were more variable, but many patients were noted to have prominent supraorbital ridges, low-set and protruding ears, and a prominent (sometimes anteverted) nasal tip"
Enumerates the recurrent facial features while recording the observer-bias caveat that keeps this from being a fixed gestalt.
Prominent supraorbital ridges HP:0000336 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Prominent supraorbital ridges (HP:0000336). HP:0000336 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:31646703 SUPPORT Human Clinical
"many patients were noted to have prominent supraorbital ridges, low-set and protruding ears, and a prominent (sometimes anteverted) nasal tip"
Reports prominent supraorbital ridges among the recurrent facial features in the 27-family series.
PMID:31341187 SUPPORT Human Clinical
"Photographs show clinical features of the six affected males who presented with a long face, pointed chin, prominent forehead, long philtrum, prominent supraorbital ridge, deep-set eyes, and low-set, protruding, large ears."
Independent five-generation pedigree documenting the same supraorbital feature.
Long philtrum HP:0000343 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Long philtrum (HP:0000343). HP:0000343 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"a long face, pointed chin, prominent forehead, long philtrum, prominent supraorbital ridge, deep-set eyes, and low-set, protruding, large ears"
Documents long philtrum among the shared facial features of the affected males.
Long face HP:0000276 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Long face (HP:0000276). HP:0000276 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
Reports a long face in all affected males of the five-generation family.
Pointed chin HP:0000307 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pointed chin (HP:0000307). HP:0000307 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
Reports a pointed chin in all affected males of the pedigree.
Prominent forehead HP:0011220 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Prominent forehead (HP:0011220). HP:0011220 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
Reports a prominent forehead in all affected males of the five-generation family.
Short neck HP:0000470 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short neck (HP:0000470). HP:0000470 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
Reports a short neck in all affected males of the pedigree.
High palate HP:0000218 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is High palate (HP:0000218). HP:0000218 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"revealed additional clinical features, such as oral-pharyngeal dysphagia, a high palate, generalized muscle hypotonia, joint hypermobility, and kyphosis"
Documents a high palate on detailed assessment of affected males.
Integument 1
Sacral dimple FREQUENT HP:0000960 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sacral dimple (HP:0000960). HP:0000960 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31646703 SUPPORT Human Clinical
"Roughly a third of the subjects have a sacral dimple"
Gives the approximate one-third proportion, which maps to the FREQUENT band.
Limbs 1
Large hands HP:0001176 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Large hands (HP:0001176). HP:0001176 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
Reports large hands in all affected males of the pedigree.
Musculoskeletal 2
Generalized hypotonia HP:0001290 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Generalized hypotonia (HP:0001290). HP:0001290 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:26637982 SUPPORT Human Clinical
"characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals"
Names generalized hypotonia as a defining feature of the syndrome.
PMID:31341187 SUPPORT Human Clinical
"revealed additional clinical features, such as oral-pharyngeal dysphagia, a high palate, generalized muscle hypotonia, joint hypermobility, and kyphosis"
Independent pedigree confirming generalized muscle hypotonia on detailed assessment.
Joint hypermobility HP:0001382 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Joint hypermobility (HP:0001382). HP:0001382 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"oral-pharyngeal dysphagia, a high palate, generalized muscle hypotonia, joint hypermobility, and kyphosis"
Documents joint hypermobility among the additional features found on comprehensive assessment.
Nervous System 9
Intellectual disability HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:26637982 SUPPORT Human Clinical
"We describe an X-linked genetic syndrome associated with mutations in TAF1 and manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals."
Names intellectual disability as a core feature of the syndrome.
PMID:31341187 SUPPORT Human Clinical
"They presented with severe (III:2 and III:5), moderate (IV:5 and V:4), or mild (III:8 and IV:1) ID."
Documents the intra-familial severity range of intellectual disability.
Global developmental delay HP:0001263 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:26637982 SUPPORT Human Clinical
"manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals"
Lists global developmental delay among the defining features.
PMID:32714589 SUPPORT Human Clinical
"We investigated the genome of a 5-year-old male who presented with global developmental delay (motor, cognitive, and speech), hypotonia, possibly ataxia, and cerebellar hypoplasia of unknown origin."
A single-patient report specifying the motor, cognitive, and speech domains involved.
Delayed speech and language development HP:0000750 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31646703 SUPPORT Human Clinical
"Delayed speech and language development were common."
Directly reports speech and language delay as common in the expanded cohort.
Autism spectrum disorder Autistic behavior HP:0000729 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Autistic behavior (HP:0000729). HP:0000729 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31646703 SUPPORT Human Clinical
"the majority of this cohort presented with hypotonia and DD during infancy, followed by later diagnoses of ID and/or ASD."
Establishes autism spectrum disorder as one of the two later diagnostic outcomes in this cohort.
Gait disturbance FREQUENT HP:0001288 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Gait disturbance (HP:0001288). HP:0001288 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31646703 SUPPORT Human Clinical
"Some form of gait disturbance was present in around a third as well."
Reports the approximate one-third proportion with gait disturbance.
Seizure OCCASIONAL HP:0001250 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Seizure (HP:0001250). HP:0001250 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:31646703 SUPPORT Human Clinical
"Other less common features included seizures, hearing loss, strabismus, and cardiac and genitourinary anomalies."
Places seizures explicitly among the less common features, supporting the OCCASIONAL band.
PMID:31646703 SUPPORT Human Clinical
"prominent among previously unreported effects were brain morphological abnormalities, seizures, hearing loss, and heart malformations"
Identifies seizures as a phenotype newly added by the broadened allelic series.
Abnormal brain morphology HP:0012443 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal brain morphology (HP:0012443). HP:0012443 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31646703 SUPPORT Human Clinical
"prominent among previously unreported effects were brain morphological abnormalities, seizures, hearing loss, and heart malformations"
Reports brain morphological abnormalities as a phenotype revealed by the broadened allelic series.
Cerebellar hypoplasia HP:0001321 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebellar hypoplasia (HP:0001321). HP:0001321 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:32714589 SUPPORT Human Clinical
"We investigated the genome of a 5-year-old male who presented with global developmental delay (motor, cognitive, and speech), hypotonia, possibly ataxia, and cerebellar hypoplasia of unknown origin."
Documents cerebellar hypoplasia in a molecularly confirmed TAF1 proband.
PMID:31341187 REFUTE Human Clinical
"Brain magnetic resonance imaging (MRI) of V:4 at two years of age identified no pathological deviations."
A normal brain MRI in an affected male from an independent pedigree contradicts cerebellar hypoplasia being a constant feature of the syndrome.
Progressive neurodegeneration in TAF1 duplication HP:0002180 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Neurodegeneration (HP:0002180). HP:0002180 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:26637982 SUPPORT Human Clinical
"Two additional families harboring large duplications involving TAF1 were also found to share phenotypic overlap with the probands harboring single-nucleotide changes, but they also demonstrated a severe neurodegeneration phenotype."
Directly reports the severe neurodegeneration phenotype specific to the duplication families.
PMID:38804708 SUPPORT Other
"Only two unrelated families carried gene duplications including TAF1 (and surrounding genes at Xq13.1), resulting in a severe progressive neurodegenerative phenotype, but with few common clinical features to cases with missense variants"
Confirms the duplication-specific progressive neurodegeneration and notes its limited clinical overlap with the missense cases.
🧬

Genetic Associations

1
TAF1
Gene: TAF1 hgnc:11535 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is TAF1 (hgnc:11535). hgnc:11535 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
X-linked recessive
Show evidence (4 references)
PMID:31646703 SUPPORT Human Clinical
"the large size of the gene (1,893 amino acids), and the fact that TATA-box binding protein-associated factor 1 (TAF1) is centrally involved in global RNA polymerase II (pol II) transcription"
Gives the size and central transcriptional role that make variant interpretation hard. Note this source's 1,893 figure differs from the 1,873 given by the TAF1 review (PMID:39323550); the notes therefore state a range rather than pick one.
PMID:31646703 SUPPORT Human Clinical
"It also illustrates the challenges for determining the pathogenicity of inherited missense variants, particularly for genes mapping to chromosome X."
Records the variant-interpretation difficulty that qualifies every reported TAF1 missense allele.
PMID:38804708 SUPPORT Other
"The TAF1 gene is located on the X chromosome (Xq13.1); thus, in males, there is only one copy, and in females, there are two, one of which undergoes X inactivation to maintain the same dosage in both sexes"
Establishes the chromosomal location and dosage context underlying the X-linked inheritance.
+ 1 more reference
Variants (4)
TAF1 c.3568C>T p.(Arg1190Cys)
Missense variant in the RAP74-interacting domain, co-segregating with X-linked intellectual disability across a five-generation family.
Show evidence (1 reference)
PMID:31341187 SUPPORT Human Clinical
"we present a five-generation family affected with X-linked intellectual disability that co-segregated with a TAF1 c.3568C>T, p.(Arg1190Cys) variant"
Reports the variant and its co-segregation with disease.
TAF1 c.4735A>G p.Ser1600Gly
Missense variant in the second bromodomain identified by combined genome and transcriptome sequencing in a proband with cerebellar hypoplasia; the carrier mother showed 90:10 skewed X-chromosome inactivation.
Show evidence (2 references)
PMID:32714589 SUPPORT Human Clinical
"By combining genome sequence data with transcriptomic data, a probable candidate variant, p.Ser1600Gly, emerged in TAF1."
Reports identification of the variant in the proband.
PMID:32714589 SUPPORT Human Clinical
"the RNA-seq data revealed a 90:10 extremely skewed X-chromosome inactivation (XCI) in the mother"
Documents the skewed XCI in the carrier mother that accompanies this variant.
TAF1 c.1A>C p.(Met1?)
Translation-initiation-codon variant found in the original Abidi syndrome family, whose lymphoblasts show reduced RAP74 phosphorylation.
Show evidence (1 reference)
PMID:42548218 SUPPORT Human Clinical
"A single base substitution that alters the translation initiation codon of TAF1, c.1A>C (p.Met1?), was found in affected males from the original Abidi syndrome family by X-exome sequencing."
Reports the variant and the family in which it segregates.
TAF1 c.4286A>C p.(Gln1429Pro)
C-terminal domain missense variant identified in a second X-linked intellectual disability family, also associated with reduced RAP74 phosphorylation.
Show evidence (1 reference)
PMID:42548218 SUPPORT Human Clinical
"A missense variant in the C-terminal domain of TAF1, c.4286A>C (p.Gln1429Pro), was identified in another XLID family including three males with intellectual disability and variable somatic features using the same approach."
Reports the variant and the family in which it was identified.
💊

Medical Actions

2
Supportive and Developmental Care
Action: supportive and developmental careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive and developmental care, annotated with Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Platform: Behavioral / lifestyle
No disease-modifying therapy exists for TAF1-related disorders. Management is supportive and developmental — early intervention, physical, speech, and occupational therapies directed at the delay, hypotonia, and gait disturbance — together with surveillance for the seizure, hearing, and cardiac features documented in the expanded allelic series.
Target Phenotypes: Global developmental delay HP:0001263 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38804708 SUPPORT Other
"Currently, there are no successful treatments for these TAF1 disorders."
Establishes the absence of disease-modifying therapy, which is why management is supportive.
Genetic Counseling
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Platform: Other
Genetic counseling addresses the X-linked recurrence risk and carrier status. Carrier mothers are typically asymptomatic with completely skewed X-chromosome inactivation, so a normal maternal phenotype does not exclude carrier status; symptomatic female carriers have also been reported.
Show evidence (2 references)
PMID:31341187 SUPPORT INDIRECT Human Clinical
"All affected males presented with intellectual disability and dysmorphic features, while heterozygous females were asymptomatic and had completely skewed X-chromosome inactivation."
Establishes the asymptomatic-carrier-female biology that makes counseling and carrier testing necessary; the paper reports the genetics, not the counseling intervention, hence INDIRECT.
PMID:38804708 SUPPORT INDIRECT Other
"many female cases are asymptomatic and were identified due to their relationship with affected male family members"
Confirms that carrier females are found through the family rather than by their own presentation, which is the counseling-relevant point.
🔬

Diagnosis

2
Exome or genome sequencing with segregation analysis
Affected males are typically ascertained through exome or genome sequencing performed for idiopathic developmental delay or intellectual disability. Because TAF1 is large, X-linked, and tolerant of many benign missense changes, a candidate variant requires familial segregation analysis and clinical phenotyping before pathogenicity can be assigned; in the largest series only a minority of candidate variants could be confidently classified. Skewed X-chromosome inactivation in the carrier mother is a supporting observation.
molecular genetic testing NCIT:C19770 NCI Thesaurus (NCIT)
Results: Identification of a hemizygous TAF1 variant in an affected male, supported by segregation with the phenotype in the family.
Show evidence (3 references)
PMID:31646703 SUPPORT Human Clinical
"Variants were identified using exome sequencing (ES) or genome sequencing (GS) primarily through clinical diagnostic testing."
States the diagnostic modality by which the cohort was ascertained.
PMID:31646703 SUPPORT Human Clinical
"Familial segregation analysis, clinical phenotyping, and bioinformatics were capitalized on to assess potential variant pathogenicity"
Describes the interpretive steps required beyond sequencing itself.
PMID:31646703 SUPPORT Human Clinical
"Most individuals were initially referred to clinics for the investigation of idiopathic-DD and/or ID."
Records the clinical indication that leads to testing.
Chromosomal microarray for the duplication lesion
Sequencing-based testing will not reliably detect the Xq13.1 duplication that constitutes the entry's second trigger lesion, so copy-number testing is the complementary diagnostic route. A reported case of floppy infant syndrome was resolved by SNP array showing an Xq13.1 duplication spanning TAF1 among other genes, with the same duplication carried by the mother and grandmother - which also illustrates the X-linked segregation the inheritance block describes.
chromosomal microarray analysis NCIT:C18477 NCI Thesaurus (NCIT)
Results: Detection of a copy-number gain at Xq13.1 encompassing TAF1 in a male with hypotonia and developmental delay.
Show evidence (2 references)
PMID:30298503 SUPPORT Human Clinical
"Single nucleotide polymorphism array (SNP array) was used for analyzing the whole genome copy number mutations in the proband."
Establishes the copy-number testing modality used to detect the duplication.
PMID:30298503 SUPPORT Human Clinical
"The multiple PCR-DHPLC assay confirmed duplication of HDAC8, PHKA1, TAF1, DLG3, KIF4A, IGBP1, PJA1 and SLC16A2 genes in the proband."
Confirms a TAF1-containing Xq13.1 duplication detected in a hypotonic infant, the lesion class the sequencing-based entry would miss.
📈

Progression

1
Infantile presentation and evolution to intellectual disability
The syndrome presents early in life with hypotonia, facial dysmorphia, and developmental delay, which evolve into a later diagnosis of intellectual disability, autism spectrum disorder, or both. Delayed speech and language development is common.
Show evidence (2 references)
PMID:31646703 SUPPORT Human Clinical
"the syndrome was defined as presenting early in life with hypotonia, facial dysmorphia, and developmental delay that evolved into intellectual disability (ID) and/or autism spectrum disorder (ASD)"
States the temporal course from infantile hypotonia and delay to the later cognitive/behavioral diagnosis.
PMID:31646703 SUPPORT Human Clinical
"the majority of this cohort presented with hypotonia and DD during infancy, followed by later diagnoses of ID and/or ASD. Delayed speech and language development were common."
Confirms the same sequence in the expanded 27-family cohort.
📊

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
No population-based prevalence estimate exists. Ascertainment is entirely from published case series: the original report described eleven families, and a subsequent genotype-first study added 27 further families, of which pathogenicity could be confidently assigned in only a subset. The count of published families, not a rate, is the available occurrence measure.
Show evidence (2 references)
PMID:31646703 SUPPORT Human Clinical
"The initial study reported eleven families, and the syndrome was defined as presenting early in life with hypotonia, facial dysmorphia, and developmental delay that evolved into intellectual disability (ID) and/or autism spectrum disorder (ASD). We have now identified an additional 27 families..."
Establishes that occurrence is documented as a count of published families rather than any population rate.
PMID:31646703 SUPPORT Human Clinical
"Despite this panoply of tools implemented, we were able to ascribe pathogenicity with confidence to only eleven of the identified de novo missense rare variant alleles, with nine in males and two in females."
Qualifies the case count — many candidate variants in the series could not be confidently called pathogenic, so the literature total overstates confirmed cases.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Intellectual Disability, X-linked, Syndromic 33:

X-linked dystonia-parkinsonism MONDO:0010747
Overlapping Features The other TAF1 disease, and the key allelic differential. XDP is caused by a Filipino founder SINE-VNTR-Alu retrotransposon insertion in intron 32 of TAF1 — a non-coding lesion — and presents in adulthood as a progressive dystonia-parkinsonism with neostriatal degeneration. MRXS33 is caused by coding missense variants (or Xq13.1 duplication) and presents congenitally as a neurodevelopmental syndrome. Both are X-linked and both involve TAF1 transcriptional dysregulation, so gene-level testing alone does not distinguish them; the lesion class does.
Distinguishing Features
  • Lesion class - intronic SVA retrotransposon insertion in XDP versus coding missense variant or Xq13.1 duplication in MRXS33
  • Age at onset - adult in XDP versus congenital/infantile in MRXS33
  • Filipino founder ancestry with a single shared haplotype in XDP
  • Progressive movement disorder with neostriatal degeneration in XDP versus developmental delay with facial dysmorphism in MRXS33
Show evidence (2 references)
PMID:38804708 SUPPORT Other
"TAF1 missense variants in human males cause X-linked intellectual disability, a neurodevelopmental disorder, and TAF1 is dysregulated in X-linked dystonia-parkinsonism, a neurodegenerative disorder."
States the allelic relationship and the neurodevelopmental versus neurodegenerative contrast that separates the two entities.
PMID:32622085 SUPPORT Other
"A non-coding 2.6 kb insertion of a SINE-VNTR-Alu (SVA)-type retrotransposon in intron 32 of TAF1 causes the neurological disorder X-linked dystonia-parkinsonism (XDP; OMIM: 313650). XDP is a progressive neurodegenerative disorder characterized by involuntary movements (dystonia), most often..."
Specifies the distinct XDP lesion and its adult-onset movement-disorder presentation.
TAF-subunit TAFopathies
Overlapping Features Pathogenic variants in other components of the TAF/TFIID complex — TBP, TAF2, and TAF6 — produce an overlapping syndrome of intellectual disability with craniofacial and cardiac anomalies, collectively termed TAFopathy. These share the general-transcription-machinery mechanism with TAF1 disease and overlap clinically, so the differential is resolved by which subunit carries the variant rather than by phenotype.
Distinguishing Features
  • Which TFIID subunit carries the variant on sequencing
  • TAF1 disease is X-linked and male-limited in practice, whereas the other TAFopathies are autosomal
Show evidence (1 reference)
PMID:37746814 SUPPORT Other
"This syndrome has been termed as a TAFopathy and includes mutations in TATA binding protein (TBP), TAF1, TAF2, and TAF6."
Names the TAFopathy group and its member genes, establishing the differential. Graded OTHER because this is the zebrafish study's background framing rather than its own human data.
🐁

Animal Models

3
Taf1 knockout mouse
The first ubiquitous Taf1 knockout mouse, generated from a validated conditional cre-lox allele. Deletion is embryonically lethal in males; heterozygous females show increased weight and reduced movement but no gross brain differences.
Species
Mouse
Genotype
Ubiquitous Taf1 knockout (conditional cre-lox allele)
Publication
PMID:38804708
Pathograph links
TAF1 Hypomorphic Missense Variants fails to recapitulate fidelity: low observes: organism A complete null does not model the human hypomorphic disease lesion: male nulls die in utero rather than developing a neurodevelopmental syndrome, and heterozygous females escape the lesion through skewed X inactivation. The link is pointed at the lesion node rather than at the downstream transcription node because a null unquestionably perturbs TFIID-dependent transcription — what it fails to reproduce is the partial-function allele the human disease actually carries.
Limitations: Male hemizygous knockout is embryonically lethal, so the genotype that corresponds to the human affected male produces no live phenotype to compare. Heterozygous females show extreme skewing toward the non-mutant chromosome, with no differences in gross brain structure, overall expression, or protein localisation, so they do not model the male syndrome either. Human disease alleles are missense and hypomorphic, not null.
Readouts
Body weight and locomotor activity in heterozygous females
Direction: ALTERED
Interpretation: The only phenotype the surviving genotype yields is a weight and movement change, interpreted by the authors as a small subset of neurons being affected — far short of the human syndrome.
Show evidence (1 reference)
PMID:38804708 SUPPORT Model Organism
"these female mice exhibited a significant increase in weight, weight with age, and reduced movement, suggesting that a small subset of neurons was negatively impacted by Taf1 loss"
Reports the measured weight and movement changes in heterozygous females.
Show evidence (2 references)
PMID:38804708 SUPPORT Model Organism
"We discovered that Taf1 deletion in male mice was embryonically lethal, which may explain why no null variants have been identified in humans."
The lethality is precisely why this model cannot reproduce the human neurodevelopmental mechanism in the corresponding genotype.
+ 1 more reference
taf1 knockout zebrafish
The first complete knockout of the TAF1 orthologue in zebrafish. The model establishes that intact taf1 is required for embryonic development and that its loss preferentially dysregulates neurodevelopmental gene sets.
Species
Zebrafish
Genotype
Complete taf1 knockout
Publication
PMID:31341187
Pathograph links
Dysregulated Neurodevelopmental Transcriptional Program perturbs fidelity: moderate observes: organism Complete loss of taf1 perturbs the transcriptional program and reveals enrichment for neurodevelopmental genes, supporting the specificity of the transcriptional lesion for neurodevelopment.
Limitations: A complete null in zebrafish is lethal during embryonic development, whereas human disease alleles are hypomorphic missense variants in surviving males, so the model perturbs the mechanism rather than reproducing the disease state.
Readouts
Neurodevelopmental gene enrichment in knockout transcriptome
Direction: ALTERED
Interpretation: Loss of taf1 shifts the transcriptome specifically toward neurodevelopmental gene sets, which is the model's central support for the transcriptional node.
Show evidence (1 reference)
PMID:31341187 SUPPORT Model Organism
"Transcriptome analysis of taf1 zebrafish knockout revealed enrichment for genes associated with neurodevelopmental processes."
Reports the transcriptomic measurement behind this readout.
Show evidence (1 reference)
PMID:31341187 SUPPORT Model Organism
"We investigated the role of TAF1 and its association to neurodevelopment by creating the first complete knockout model of the TAF1 orthologue in zebrafish."
Establishes the model and its purpose as a perturbation of TAF1 function.
TAF1 Hypomorphic Missense Variants measures fidelity: moderate observes: organism The model provides the organismal evidence that complete TAF1 loss is not viable, which is the basis for interpreting human disease alleles as hypomorphic rather than null.
Limitations: Embryonic lethality in zebrafish is evidence about the null state, not about any specific human missense allele's residual activity.
Show evidence (1 reference)
PMID:31341187 SUPPORT Model Organism
"A crucial function of human TAF1 during embryogenesis can be inferred from the model, demonstrating that intact taf1 is essential for embryonic development."
Supplies the essentiality result that constrains the human allelic spectrum to hypomorphs.
CRISPR/Cas9 TAF1-edited rat
A somatic brain transgenesis model in which TAF1 is deleted in the postnatal rat brain by intracerebroventricular delivery of lentiviral CRISPR/Cas9. It was developed specifically because embryonic mouse knockouts of TAF1 had failed, and it produces behavioral deficits with cerebellar Purkinje cell pathology.
Species
Rat
Genotype
Somatic brain TAF1 deletion by lentiviral CRISPR/Cas9 (gRNA-TAF1, intracerebroventricular)
Publication
PMID:31344492
Pathograph links
Cerebellar Purkinje Cell Loss recapitulates fidelity: moderate observes: tissue TAF1 deletion in the developing rat brain produces Purkinje cell hypoplasia and loss with reduced CaV3.1 expression and associated motor deficits — the observations that define this node.
Limitations: The lesion is a somatic postnatal deletion delivered to part of the brain, not a germline hypomorphic missense allele present from conception, and no human MRXS33 neuropathology exists against which to check the Purkinje finding.
Readouts
Purkinje cell number and cerebellar morphology
Direction: DECREASED
Interpretation: Direct histopathological correlate of the Purkinje cell loss node.
Show evidence (1 reference)
PMID:31344492 SUPPORT Model Organism
"Deletion of TAF1 lead to a hypoplasia and loss of the Purkinje cells."
Reports the histological measurement behind this readout.
CaV3.1 T-type calcium channel expression
Direction: DECREASED
Interpretation: Reduced presynaptic CaV3.1 is the channel-level change the authors link to irregular cerebellar output in this model.
Show evidence (1 reference)
PMID:31344492 SUPPORT Model Organism
"Immunostaining revealed a reduction in the expression of the CaV3.1 T-type calcium channel."
Reports the immunostaining measurement behind this readout.
Behavioral response to the T-type calcium channel enhancer SAK3
Direction: RESTORED
Interpretation: Pharmacological rescue in the same model. SAK3 is a preclinical tool compound in rats; it is not a treatment for the human disease and is deliberately not curated in the treatments section.
Show evidence (2 references)
PMID:32622085 SUPPORT Model Organism
"Oral administration of SAK3 (0.25 mg/kg, p.o.) significantly rescued the behavior abnormalities in beam walking test and open field test caused by TAF1 gene editing."
Reports the behavioral rescue measurement in the TAF1-edited rat.
+ 1 more reference
Cortical neuron and astrocyte survival under SAK3
Direction: RESTORED
Interpretation: The same compound protects cortical neurons and astrocytes and restores BDNF/AKT/GSK3-beta signaling, indicating the rescue is not confined to the cerebellum. Recorded here because the companion study shares the model; it is a preclinical rat result, not a human therapy.
Show evidence (2 references)
PMID:33359140 SUPPORT Model Organism
"SAK3 treatment prevented the loss of cortical neurons and GFAP-positive astrocytes observed after TAF1 gene editing."
Reports the cortical neuron and astrocyte protection measurement in the same TAF1-edited rat model.
+ 1 more reference
Show evidence (1 reference)
PMID:31344492 SUPPORT Model Organism
"Here, we report the development and characterization of a novel animal model for TAF1 ID syndrome in which the TAF1 gene is deleted in embryonic rats using clustered regularly interspaced short palindromic repeats (CRISPR) associated protein 9 (Cas9) technology and somatic brain transgenesis..."
Establishes the model as purpose-built for TAF1 ID syndrome, supporting its use as informative for this node.
{ }

Source YAML

click to show 
name: Intellectual Disability, X-linked, Syndromic 33
creation_date: "2026-09-04T00:00:00Z"
category: Mendelian
disease_term:
  preferred_term: TAF1 intellectual disability syndrome
  term:
    id: MONDO:0010500
    label: intellectual disability, X-linked, syndromic 33
parents:
- X-linked syndromic intellectual disability
- multiple congenital anomalies/dysmorphic syndrome-intellectual disability
synonyms:
- MRXS33
- Abidi syndrome
- TAF1 intellectual disability syndrome
- TAF1/MRXS33 intellectual disability syndrome
- X-linked syndromic intellectual disability caused by mutation in TAF1
- mental retardation, X-linked, syndromic 33
- X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome
description: >
  Intellectual disability, X-linked, syndromic 33 (MRXS33; TAF1 intellectual
  disability syndrome) is an X-linked neurodevelopmental disorder of affected
  males caused by germline variants in TAF1, which encodes the largest subunit
  of the general transcription factor TFIID. Affected boys present early with
  generalized hypotonia, global developmental delay, and characteristic facial
  dysmorphology, evolving into intellectual disability and/or autism spectrum
  disorder; a broadened allelic series adds brain morphological abnormalities,
  seizures, hearing loss, and heart malformations. Reported disease alleles are
  predominantly missense, with a start-loss variant, a splice-site variant, and
  two locus duplications also described. Complete TAF1 loss is embryonic-lethal
  in mouse and zebrafish, and no hemizygous null alleles of the canonical
  coding isoform are seen in population databases, so the disorder is best
  understood as a hypomorphic, dosage- and activity-sensitive lesion of the RNA
  polymerase II preinitiation machinery rather than a null. Two families with large Xq13.1 duplications involving
  TAF1 overlap the missense phenotype but additionally show severe progressive
  neurodegeneration.

  MRXS33 is allelic to, and clinically distinct from, X-linked
  dystonia-parkinsonism (XDP, curated separately in this knowledge base). XDP
  arises from a Filipino founder SINE-VNTR-Alu retrotransposon insertion in
  intron 32 of TAF1 and is an adult-onset neurodegenerative movement disorder
  with neostriatal neuronal loss; MRXS33 arises from coding missense variants
  (or locus duplication) and is a congenital neurodevelopmental syndrome. The
  two share a gene and a broad theme of TAF1 transcriptional dysregulation, but
  differ in lesion class, age of onset, neuroanatomical target, and clinical
  syndrome.

references:
- reference: PMID:26637982
  title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
- reference: PMID:31646703
  title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."

inheritance:
- name: X-linked recessive
  inheritance_term:
    preferred_term: X-linked recessive inheritance
    term:
      id: HP:0001419
      label: X-linked recessive inheritance
  description: >
    TAF1 maps to Xq13.1 and the syndrome manifests in hemizygous males, with
    variants arising de novo or inherited from an unaffected carrier mother.
    Heterozygous carrier females are typically asymptomatic in association with
    completely skewed X-chromosome inactivation toward the non-mutant
    chromosome, although symptomatic females carrying TAF1 variants have also
    been reported.
  evidence:
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe an X-linked genetic syndrome associated with mutations in TAF1 and manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals."
    explanation: The original description establishes X-linked transmission with disease manifest in males.
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected males presented with intellectual disability and dysmorphic features, while heterozygous females were asymptomatic and had completely skewed X-chromosome inactivation."
    explanation: A five-generation pedigree showing male-limited expression with skewed XCI in asymptomatic carrier females, the pattern that makes the inheritance recessive in practice.
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Simultaneous studies using diverse strategies led to the identification of nine families with overlapping clinical presentations and affected by de novo or maternally inherited single-nucleotide changes."
    explanation: Documents both de novo and maternally inherited origins of the causal single-nucleotide changes.
  - reference: PMID:38804708
    reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "TAF1 missense variants in females have been reported with similar phenotypes as those in males"
    explanation: Supports the clause that carrier females are not invariably asymptomatic. Graded OTHER because this is the mouse study's background summary of others' human reports rather than its own clinical data.
  - reference: PMID:32564284
    reference_title: "Understanding the Landscape of X-linked Variants Causing Intellectual Disability in Females Through Extreme X Chromosome Inactivation Skewing."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "and four single nucleotide variants in NLGN4X, HDAC8, TAF1, and USP9X genes, two of which affecting XCI escape genes"
    explanation: A TAF1 single-nucleotide variant found in a female with idiopathic intellectual disability and extreme XCI skewing. Marked INDIRECT because the study classes these as XLID-potentially related rather than confirmed causal in that individual.

prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >
    No population-based prevalence estimate exists. Ascertainment is entirely
    from published case series: the original report described eleven families,
    and a subsequent genotype-first study added 27 further families, of which
    pathogenicity could be confidently assigned in only a subset. The count of
    published families, not a rate, is the available occurrence measure.
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The initial study reported eleven families, and the syndrome was defined as presenting early in life with hypotonia, facial dysmorphia, and developmental delay that evolved into intellectual disability (ID) and/or autism spectrum disorder (ASD). We have now identified an additional 27 families through a genotype-first approach."
    explanation: Establishes that occurrence is documented as a count of published families rather than any population rate.
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Despite this panoply of tools implemented, we were able to ascribe pathogenicity with confidence to only eleven of the identified de novo missense rare variant alleles, with nine in males and two in females."
    explanation: Qualifies the case count — many candidate variants in the series could not be confidently called pathogenic, so the literature total overstates confirmed cases.

progression:
- phase: Infantile presentation and evolution to intellectual disability
  notes: >
    The syndrome presents early in life with hypotonia, facial dysmorphia, and
    developmental delay, which evolve into a later diagnosis of intellectual
    disability, autism spectrum disorder, or both. Delayed speech and language
    development is common.
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the syndrome was defined as presenting early in life with hypotonia, facial dysmorphia, and developmental delay that evolved into intellectual disability (ID) and/or autism spectrum disorder (ASD)"
    explanation: States the temporal course from infantile hypotonia and delay to the later cognitive/behavioral diagnosis.
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the majority of this cohort presented with hypotonia and DD during infancy, followed by later diagnoses of ID and/or ASD. Delayed speech and language development were common."
    explanation: Confirms the same sequence in the expanded 27-family cohort.

phenotypes:
- name: Intellectual disability
  description: >
    Intellectual disability is the defining cognitive outcome, ranging from
    mild to severe within a single pedigree.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe an X-linked genetic syndrome associated with mutations in TAF1 and manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals."
    explanation: Names intellectual disability as a core feature of the syndrome.
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They presented with severe (III:2 and III:5), moderate (IV:5 and V:4), or mild (III:8 and IV:1) ID."
    explanation: Documents the intra-familial severity range of intellectual disability.
- name: Global developmental delay
  description: >
    Global developmental delay across motor, cognitive, and speech domains is
    present in infancy and precedes the diagnosis of intellectual disability.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals"
    explanation: Lists global developmental delay among the defining features.
  - reference: PMID:32714589
    reference_title: "A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We investigated the genome of a 5-year-old male who presented with global developmental delay (motor, cognitive, and speech), hypotonia, possibly ataxia, and cerebellar hypoplasia of unknown origin."
    explanation: A single-patient report specifying the motor, cognitive, and speech domains involved.
- name: Generalized hypotonia
  description: >
    Generalized muscle hypotonia is an early and characteristic finding,
    typically noted during infancy.
  phenotype_term:
    preferred_term: Generalized hypotonia
    term:
      id: HP:0001290
      label: Generalized hypotonia
  evidence:
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals"
    explanation: Names generalized hypotonia as a defining feature of the syndrome.
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "revealed additional clinical features, such as oral-pharyngeal dysphagia, a high palate, generalized muscle hypotonia, joint hypermobility, and kyphosis"
    explanation: Independent pedigree confirming generalized muscle hypotonia on detailed assessment.
- name: Delayed speech and language development
  description: >
    Speech and language delay is a common component of the developmental
    profile.
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Delayed speech and language development were common."
    explanation: Directly reports speech and language delay as common in the expanded cohort.
- name: Autism spectrum disorder
  description: >
    Autism spectrum disorder is diagnosed in a proportion of affected
    individuals, in some cases alongside and in others instead of a formal
    intellectual disability diagnosis.
  phenotype_term:
    preferred_term: Autistic behavior
    term:
      id: HP:0000729
      label: Autistic behavior
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the majority of this cohort presented with hypotonia and DD during infancy, followed by later diagnoses of ID and/or ASD."
    explanation: Establishes autism spectrum disorder as one of the two later diagnostic outcomes in this cohort.
- name: Characteristic facial dysmorphism
  description: >
    A recognizable but observer-dependent facial gestalt. Recurrent features
    across series include prominent supraorbital ridges, low-set and protruding
    ears, a prominent nasal tip, a long face, a long philtrum, and a pointed
    chin.
  phenotype_term:
    preferred_term: Abnormal facial shape
    term:
      id: HP:0001999
      label: Abnormal facial shape
  sequelae:
  - target: Prominent supraorbital ridges
  - target: Low-set ears
  - target: Protruding ear
  - target: Long philtrum
  - target: Long face
  - target: Pointed chin
  - target: Prominent forehead
  - target: Short neck
  evidence:
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features"
    explanation: Establishes characteristic facial dysmorphology as a defining feature.
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Dysmorphic facial features, which are particularly prone to observer bias, were more variable, but many patients were noted to have prominent supraorbital ridges, low-set and protruding ears, and a prominent (sometimes anteverted) nasal tip"
    explanation: Enumerates the recurrent facial features while recording the observer-bias caveat that keeps this from being a fixed gestalt.
- name: Prominent supraorbital ridges
  description: >
    Prominent supraorbital ridges are among the most consistently reported
    facial features across independent pedigrees.
  phenotype_term:
    preferred_term: Prominent supraorbital ridges
    term:
      id: HP:0000336
      label: Prominent supraorbital ridges
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "many patients were noted to have prominent supraorbital ridges, low-set and protruding ears, and a prominent (sometimes anteverted) nasal tip"
    explanation: Reports prominent supraorbital ridges among the recurrent facial features in the 27-family series.
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Photographs show clinical features of the six affected males who presented with a long face, pointed chin, prominent forehead, long philtrum, prominent supraorbital ridge, deep-set eyes, and low-set, protruding, large ears."
    explanation: Independent five-generation pedigree documenting the same supraorbital feature.
- name: Low-set ears
  description: Low-set ears are a recurrent feature of the facial gestalt.
  phenotype_term:
    preferred_term: Low-set ears
    term:
      id: HP:0000369
      label: Low-set ears
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "who presented with a long face, pointed chin, prominent forehead, long philtrum, prominent supraorbital ridge, deep-set eyes, and low-set, protruding, large ears"
    explanation: Documents low-set ears in all six affected males of the pedigree.
- name: Protruding ear
  description: Protruding, often large ears accompany the low-set ear position.
  phenotype_term:
    preferred_term: Protruding ear
    term:
      id: HP:0000411
      label: Protruding ear
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "many patients were noted to have prominent supraorbital ridges, low-set and protruding ears, and a prominent (sometimes anteverted) nasal tip"
    explanation: Reports protruding ears among the recurrent facial features.
- name: Long philtrum
  description: A long philtrum is part of the recurrent facial pattern.
  phenotype_term:
    preferred_term: Long philtrum
    term:
      id: HP:0000343
      label: Long philtrum
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a long face, pointed chin, prominent forehead, long philtrum, prominent supraorbital ridge, deep-set eyes, and low-set, protruding, large ears"
    explanation: Documents long philtrum among the shared facial features of the affected males.
- name: Long face
  description: A long face with a pointed chin recurs across affected males.
  phenotype_term:
    preferred_term: Long face
    term:
      id: HP:0000276
      label: Long face
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
    explanation: Reports a long face in all affected males of the five-generation family.
- name: Pointed chin
  description: A pointed chin accompanies the long face in the facial gestalt.
  phenotype_term:
    preferred_term: Pointed chin
    term:
      id: HP:0000307
      label: Pointed chin
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
    explanation: Reports a pointed chin in all affected males of the pedigree.
- name: Prominent forehead
  description: A prominent forehead is part of the recurrent facial pattern.
  phenotype_term:
    preferred_term: Prominent forehead
    term:
      id: HP:0011220
      label: Prominent forehead
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
    explanation: Reports a prominent forehead in all affected males of the five-generation family.
- name: Large hands
  description: Large hands accompany the facial features in the affected males.
  phenotype_term:
    preferred_term: Large hands
    term:
      id: HP:0001176
      label: Large hands
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
    explanation: Reports large hands in all affected males of the pedigree.
- name: Short neck
  description: A short neck is reported across the affected males of the pedigree.
  phenotype_term:
    preferred_term: Short neck
    term:
      id: HP:0000470
      label: Short neck
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected males had a long face, pointed chin, large hands, prominent forehead, short neck, and low-set, protruding, large ears."
    explanation: Reports a short neck in all affected males of the pedigree.
- name: High palate
  description: >
    A high palate was found on comprehensive clinical assessment, alongside the
    dysphagia and hypotonia findings.
  phenotype_term:
    preferred_term: High palate
    term:
      id: HP:0000218
      label: High palate
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "revealed additional clinical features, such as oral-pharyngeal dysphagia, a high palate, generalized muscle hypotonia, joint hypermobility, and kyphosis"
    explanation: Documents a high palate on detailed assessment of affected males.
- name: Sacral dimple
  description: >
    A sacral dimple, part of the abnormal gluteal-crease and sacral caudal
    remnant feature that gives this syndrome one of its clinical names, occurs
    in roughly a third of affected individuals.
  phenotype_term:
    preferred_term: Sacral dimple
    term:
      id: HP:0000960
      label: Sacral dimple
  frequency: FREQUENT
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Roughly a third of the subjects have a sacral dimple"
    explanation: Gives the approximate one-third proportion, which maps to the FREQUENT band.
- name: Gait disturbance
  description: >
    Some form of gait disturbance is present in approximately a third of
    affected individuals.
  phenotype_term:
    preferred_term: Gait disturbance
    term:
      id: HP:0001288
      label: Gait disturbance
  frequency: FREQUENT
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Some form of gait disturbance was present in around a third as well."
    explanation: Reports the approximate one-third proportion with gait disturbance.
- name: Seizure
  description: >
    Seizures are a less common feature that emerged in the expanded allelic
    series and were not part of the original phenotype description.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other less common features included seizures, hearing loss, strabismus, and cardiac and genitourinary anomalies."
    explanation: Places seizures explicitly among the less common features, supporting the OCCASIONAL band.
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "prominent among previously unreported effects were brain morphological abnormalities, seizures, hearing loss, and heart malformations"
    explanation: Identifies seizures as a phenotype newly added by the broadened allelic series.
- name: Hearing impairment
  description: >
    Hearing loss is a less common feature identified through the expanded
    allelic series.
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other less common features included seizures, hearing loss, strabismus, and cardiac and genitourinary anomalies."
    explanation: Lists hearing loss among the less common features of the syndrome.
- name: Strabismus
  description: Strabismus is reported among the less common features.
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other less common features included seizures, hearing loss, strabismus, and cardiac and genitourinary anomalies."
    explanation: Lists strabismus among the less common features.
- name: Genitourinary anomaly
  description: >
    Genitourinary anomalies are reported among the less common features of the
    syndrome, in the same series sentence that records the seizure, hearing and
    cardiac findings.
  phenotype_term:
    preferred_term: Abnormality of the genitourinary system
    term:
      id: HP:0000119
      label: Abnormality of the genitourinary system
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other less common features included seizures, hearing loss, strabismus, and cardiac and genitourinary anomalies."
    explanation: Lists genitourinary anomalies among the less common features, supporting the OCCASIONAL band.
- name: Congenital heart malformation
  description: >
    Heart malformations were among the previously unreported effects that
    emerged when the allelic series was broadened, and congenital heart disease
    is part of the wider TAFopathy phenotype shared with other TAF-subunit
    disorders.
  phenotype_term:
    preferred_term: Abnormal heart morphology
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "prominent among previously unreported effects were brain morphological abnormalities, seizures, hearing loss, and heart malformations"
    explanation: Identifies heart malformations as part of the broadened phenotypic spectrum.
  - reference: PMID:37746814
    reference_title: "Deletion of taf1 and taf5 in zebrafish capitulate cardiac and craniofacial abnormalities associated with TAFopathies through perturbations in metabolism."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Pathogenic variants in components of TATA-binding protein associated factors (TAFs) have recently been identified in a subset of patients with intellectual disability, craniofacial hypoplasia, and congenital heart disease."
    explanation: Places congenital heart disease in the shared TAFopathy phenotype of which TAF1 disease is a member. This is a background statement in a zebrafish study summarizing others' human findings, hence OTHER rather than HUMAN_CLINICAL.
- name: Abnormal brain morphology
  description: >
    Brain morphological abnormalities emerged from the expanded series;
    cerebellar hypoplasia has been documented in an individual case, and
    hypoplasia of the corpus callosum is recorded across previously reported
    patients.
  phenotype_term:
    preferred_term: Abnormal brain morphology
    term:
      id: HP:0012443
      label: Abnormal brain morphology
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "prominent among previously unreported effects were brain morphological abnormalities, seizures, hearing loss, and heart malformations"
    explanation: Reports brain morphological abnormalities as a phenotype revealed by the broadened allelic series.
- name: Cerebellar hypoplasia
  description: >
    Cerebellar hypoplasia was the presenting neuroimaging finding in a
    genome-sequenced proband with a TAF1 p.Ser1600Gly variant. It is not a
    universal feature: brain MRI was normal in an affected male from an
    independent pedigree.
  phenotype_term:
    preferred_term: Cerebellar hypoplasia
    term:
      id: HP:0001321
      label: Cerebellar hypoplasia
  evidence:
  - reference: PMID:32714589
    reference_title: "A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We investigated the genome of a 5-year-old male who presented with global developmental delay (motor, cognitive, and speech), hypotonia, possibly ataxia, and cerebellar hypoplasia of unknown origin."
    explanation: Documents cerebellar hypoplasia in a molecularly confirmed TAF1 proband.
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Brain magnetic resonance imaging (MRI) of V:4 at two years of age identified no pathological deviations."
    explanation: A normal brain MRI in an affected male from an independent pedigree contradicts cerebellar hypoplasia being a constant feature of the syndrome.
- name: Oral-pharyngeal dysphagia
  description: >
    Oral-pharyngeal dysphagia was identified on comprehensive clinical
    assessment of affected males.
  phenotype_term:
    preferred_term: Oral-pharyngeal dysphagia
    term:
      id: HP:0200136
      label: Oral-pharyngeal dysphagia
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "revealed additional clinical features, such as oral-pharyngeal dysphagia, a high palate, generalized muscle hypotonia, joint hypermobility, and kyphosis"
    explanation: Documents oral-pharyngeal dysphagia on detailed assessment of affected males.
- name: Joint hypermobility
  description: Joint hypermobility is part of the connective-tissue-like findings on detailed assessment.
  phenotype_term:
    preferred_term: Joint hypermobility
    term:
      id: HP:0001382
      label: Joint hypermobility
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "oral-pharyngeal dysphagia, a high palate, generalized muscle hypotonia, joint hypermobility, and kyphosis"
    explanation: Documents joint hypermobility among the additional features found on comprehensive assessment.
- name: Progressive neurodegeneration in TAF1 duplication
  description: >
    The two reported families with large Xq13.1 duplications involving TAF1
    overlap the missense phenotype but additionally show a severe progressive
    neurodegenerative course. This distinguishes the duplication lesion from
    the missense lesion and is the feature that most resembles the allelic
    XDP phenotype.
  phenotype_term:
    preferred_term: Neurodegeneration
    term:
      id: HP:0002180
      label: Neurodegeneration
  evidence:
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Two additional families harboring large duplications involving TAF1 were also found to share phenotypic overlap with the probands harboring single-nucleotide changes, but they also demonstrated a severe neurodegeneration phenotype."
    explanation: Directly reports the severe neurodegeneration phenotype specific to the duplication families.
  - reference: PMID:38804708
    reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Only two unrelated families carried gene duplications including TAF1 (and surrounding genes at Xq13.1), resulting in a severe progressive neurodegenerative phenotype, but with few common clinical features to cases with missense variants"
    explanation: Confirms the duplication-specific progressive neurodegeneration and notes its limited clinical overlap with the missense cases.

pathophysiology:
- name: TAF1 Hypomorphic Missense Variants
  role: trigger
  biological_scale: MOLECULAR
  description: >
    Germline missense variants across the TAF1 coding sequence are the
    predominant disease lesion. Reported alleles are almost exclusively
    missense, and hemizygous or homozygous loss-of-function alleles are absent
    from population databases, which together with embryonic lethality of null
    alleles in mouse and zebrafish indicates that surviving disease alleles are
    hypomorphic rather than null.
  genes:
  - preferred_term: TAF1
    term:
      id: hgnc:11535
      label: TAF1
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To date, only missense variants have been found; the lack of hemi- and homozygous loss-of-function variants in the protein coding part of the canonical TAF1 isoform in human population databases suggests that the complete loss of TAF1 may be embryonic-lethal."
    explanation: Establishes both the missense-only allelic spectrum and the inference that complete loss is not compatible with life, which is what makes the disease alleles hypomorphic.
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our results suggest that mutations in TAF1 play a critical role in the development of this X-linked ID syndrome."
    explanation: The original series' conclusion that TAF1 mutation is causal for the syndrome.
  downstream:
  - target: Loss of TAF1 Bromodomain Repression in Cardiogenesis
    causal_link_type: DIRECT
    description: >
      Damaging missense variants falling in the C-terminal bromodomain abolish
      its repressive function directly, shown by mutational analysis of
      patient-derived variants.
    evidence:
    - reference: PMID:36958711
      reference_title: "TAF1 bromodomain inhibition as a candidate epigenetic driver of congenital heart disease."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "demonstrating a repressive role of TAF1 that can be abrogated by the introduction of damaging bromodomain variants"
      explanation: The patient-derived variants themselves abrogate the repression, making this step direct rather than inferred.
  - target: Reduced RAP74 Phosphorylation in Patient Cells
    causal_link_type: DIRECT
    description: >
      Patient-derived lymphoblasts carrying the causal variants show reduced
      RAP74 phosphorylation. The variant-to-phosphorylation observation is
      direct; the mechanism connecting them is not settled (see the node).
    evidence:
    - reference: PMID:42548218
      reference_title: "Abidi Syndrome and Another Family With X-Linked Intellectual Disability Have TAF1 Variants and Reduced Phosphorylation of RNA Polymerase II Associated Protein 74."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Lymphoblasts carrying either the p.Met1? or the p.Gln1429Pro variants from probands in these two families were studied using a phosphorylation-specific antibody and found to have reduced phosphorylation of RAP74."
      explanation: Patient-derived lymphoblasts carrying the causal variants directly show the reduced phosphorylation, linking variant to kinase defect.
  - target: TFIID-Dependent Transcription Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      TAF1 is the largest subunit of TFIID and directs assembly of the RNA
      polymerase II preinitiation complex, so a hypomorphic TAF1 is presumed to
      degrade that function. No cited study measures preinitiation complex
      assembly or TFIID function in patient material, so this edge rests on
      TAF1's known normal role rather than on a measured defect.
    evidence:
    - reference: PMID:31646703
      reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: OTHER
      snippet: "TAF1 encodes the largest subunit of the basal transcription factor II D (TFIID), which directs the assembly of the pol II preinitiation complex"
      explanation: Establishes TAF1's normal role in preinitiation complex assembly; the inference that a hypomorphic allele impairs it is an added step this quote does not itself make.
- name: Loss of TAF1 Bromodomain Repression in Cardiogenesis
  role: intermediate
  biological_scale: MOLECULAR
  description: >
    TAF1's C-terminal bromodomain exerts a repressive role during
    cardiogenesis. Damaging bromodomain missense variants taken from congenital
    heart disease patients abrogate that repression, and a selective chemical
    inhibitor of the TAF1 bromodomain reproduces the same effect - it was
    recovered in an unbiased screen as an activator of atrial and ventricular
    fetal myosins during pluripotent stem cell differentiation. This is the
    entry's only mechanism-level account of the cardiac phenotype, and it is
    specific to the bromodomain variant class rather than to TAF1 variants
    generally.
  evidence:
  - reference: PMID:36958711
    reference_title: "TAF1 bromodomain inhibition as a candidate epigenetic driver of congenital heart disease."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Damaging TAF1 missense variants from CHD patients were studied by mutational analysis of the TAF1 bromodomain, demonstrating a repressive role of TAF1 that can be abrogated by the introduction of damaging bromodomain variants or chemical TAF1 bromodomain inhibition."
    explanation: Establishes both the repressive bromodomain function and its abrogation by patient-derived damaging variants, which is the node's central claim.
  - reference: PMID:36958711
    reference_title: "TAF1 bromodomain inhibition as a candidate epigenetic driver of congenital heart disease."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "TAF1 bromodomain inhibitors were tested for their effects on stem cell viability and cardiomyocyte differentiation, implicating a role for TAF1 in cardiogenesis."
    explanation: Independent pharmacological arm implicating TAF1 in cardiomyocyte differentiation, corroborating the genetic result.
  downstream:
  - target: Congenital heart malformation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Derepression of TAF1 bromodomain targets during cardiogenesis is the
      proposed route to the congenital heart malformations seen in patients
      carrying damaging bromodomain variants. The work is done in stem-cell
      differentiation and in vitro mutational analysis, not in patient hearts,
      so the intervening steps to a formed cardiac malformation are not
      established.
    evidence:
    - reference: PMID:36958711
      reference_title: "TAF1 bromodomain inhibition as a candidate epigenetic driver of congenital heart disease."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: IN_VITRO
      snippet: "Attributing the effects of congenital heart disease (CHD) missense variants to disruption of specific protein domains allows for a mechanistic understanding of CHDs and improved diagnostics."
      explanation: States the study's aim of linking CHD missense variants to a specific domain mechanism; the link from that in vitro mechanism to the formed human malformation is the inference this edge records.
    - reference: PMID:37746814
      reference_title: "Deletion of taf1 and taf5 in zebrafish capitulate cardiac and craniofacial abnormalities associated with TAFopathies through perturbations in metabolism."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "CRISPR/CAS9 mediated gene editing revealed that these defects where phenocopied by mutations in taf1 and taf5."
      explanation: An orthogonal whole-organism result showing taf1 mutation phenocopies the cardiac and craniofacial defects, supporting a genuine cardiac consequence of TAF1 loss.
- name: TAF1 Locus Duplication
  role: trigger
  biological_scale: MOLECULAR
  description: >
    A second, distinct initiating lesion: large duplications at Xq13.1
    encompassing TAF1 and neighboring genes. These families overlap the
    missense phenotype but add severe progressive neurodegeneration, so the
    duplication is modeled as its own trigger rather than as a variant class
    of the missense lesion.
  genes:
  - preferred_term: TAF1
    term:
      id: hgnc:11535
      label: TAF1
  evidence:
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Two additional families harboring large duplications involving TAF1 were also found to share phenotypic overlap with the probands harboring single-nucleotide changes, but they also demonstrated a severe neurodegeneration phenotype."
    explanation: Identifies the duplication lesion and its distinct additional phenotype.
  downstream:
  - target: Progressive neurodegeneration in TAF1 duplication
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      The duplication families show severe progressive neurodegeneration, but
      the duplications span genes beyond TAF1 and no intervening mechanism has
      been established, so the route from duplication to neurodegeneration is
      recorded as unresolved.
    evidence:
    - reference: PMID:38804708
      reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Only two unrelated families carried gene duplications including TAF1 (and surrounding genes at Xq13.1), resulting in a severe progressive neurodegenerative phenotype, but with few common clinical features to cases with missense variants"
      explanation: Reports the duplication-to-neurodegeneration association while noting the duplications include surrounding genes, which is why the intermediates are treated as unknown.
  - target: TFIID-Dependent Transcription Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Increased TAF1 dosage is presumed to perturb the same TFIID-dependent
      transcriptional function that the missense alleles impair, but no direct
      measurement of TFIID function in duplication carriers has been reported.
    evidence:
    - reference: PMID:26637982
      reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Two additional families harboring large duplications involving TAF1 were also found to share phenotypic overlap with the probands harboring single-nucleotide changes"
      explanation: The shared phenotypic overlap is the basis for convergence on a common transcriptional mechanism; the mechanism itself is not directly demonstrated in these families.
- name: Reduced RAP74 Phosphorylation in Patient Cells
  role: intermediate
  biological_scale: MOLECULAR
  description: >
    Lymphoblasts from probands carrying two independent pathogenic TAF1
    variants show reduced phosphorylation of RNA polymerase II-associated
    protein 74 (RAP74). The curated observation here is that measured
    reduction in RAP74 phosphorylation, not the identity of the responsible
    kinase. PMID:42548218 attributes the activity to TAF1's own N- and
    C-terminal serine/threonine kinase domains, but a 2024 TAF1 review reports
    that the enzymatic activities historically attributed to TAF1 — kinase
    among them — could not be confirmed in recent TFIID/TAF1 studies and that
    much of the underlying work has been retracted. This node therefore does
    not bind a TAF1 kinase molecular function, and the route onward to
    transcriptional dysfunction is hypothesis-scoped.
  evidence:
  - reference: PMID:42548218
    reference_title: "Abidi Syndrome and Another Family With X-Linked Intellectual Disability Have TAF1 Variants and Reduced Phosphorylation of RNA Polymerase II Associated Protein 74."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The N- and C-terminal domains of TAF1 are known to possess a serine/threonine kinase activity that selectively phosphorylates RNA polymerase II-associated protein 74 (RAP74)."
    explanation: The source of the attributed TAF1 kinase activity, recorded here as the claim this paper makes rather than as established fact - see the REFUTE item below.
  - reference: PMID:39323550
    reference_title: "The roles of TAF1 in neuroscience and beyond."
    supports: REFUTE
    evidence_source: OTHER
    snippet: "several enzymatic activities have been attributed to TAF1 in the past, which could not be confirmed in recent TFIID and/or TAF1 studies. These include kinase, histone acetylation and ubiquitination activities"
    explanation: Contradicts the premise that TAF1 itself is the kinase acting on RAP74, which is why this node curates the measured phosphorylation change rather than a TAF1 kinase activity.
  - reference: PMID:42548218
    reference_title: "Abidi Syndrome and Another Family With X-Linked Intellectual Disability Have TAF1 Variants and Reduced Phosphorylation of RNA Polymerase II Associated Protein 74."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "This study expands the phenotypic spectrum of TAF1-related XLID and implicates reduced RAP74 phosphorylation as a potential mechanism."
    explanation: States the authors' mechanistic inference, while its hedged wording is why this node is not treated as an established step.
  downstream:
  - target: TFIID-Dependent Transcription Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      RAP74 is a subunit of TFIIF, a general transcription factor that acts in
      preinitiation complex assembly as well as elongation, so reduced
      phosphorylation is proposed to feed into the general transcription
      defect. The cited study frames this as a potential mechanism rather than
      a demonstrated route.
    hypothesis_groups:
    - rap74_phosphorylation_route
    evidence:
    - reference: PMID:42548218
      reference_title: "Abidi Syndrome and Another Family With X-Linked Intellectual Disability Have TAF1 Variants and Reduced Phosphorylation of RNA Polymerase II Associated Protein 74."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "implicates reduced RAP74 phosphorylation as a potential mechanism"
      explanation: The source explicitly labels this a potential mechanism, which is what the hypothesis-scoped edge records.
- name: TFIID-Dependent Transcription Dysfunction
  role: intermediate
  biological_scale: MOLECULAR
  description: >
    TAF1 is the largest subunit of TFIID, which with TATA-binding protein and
    the other TBP-associated factors nucleates the RNA polymerase II
    preinitiation complex at essentially all pol II promoters. A TAF1 lesion
    therefore perturbs a general transcription function rather than a single
    target pathway. The node is tagged DYSREGULATED rather than DECREASED
    because it has two upstream lesions pushing in opposite directions —
    hypomorphic missense alleles reducing TAF1 function and Xq13.1
    duplications increasing TAF1 dosage — and because no study has measured
    preinitiation complex assembly in patient material in either direction.
  biological_processes:
  - preferred_term: RNA polymerase II preinitiation complex assembly
    term:
      id: GO:0051123
      label: RNA polymerase II preinitiation complex assembly
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "TAF1 encodes the largest subunit of the basal transcription factor II D (TFIID), which directs the assembly of the pol II preinitiation complex (Papai, Weil, & Schultz, 2011) and is likely required for all pol II gene promoters"
    explanation: Establishes TAF1's role in preinitiation complex assembly and the generality of that requirement.
  - reference: PMID:39323550
    reference_title: "The roles of TAF1 in neuroscience and beyond."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "TAF1 is best known for being part of a protein complex with TBP and other TAFs, forming the basal transcription factor IID (TFIID), which is an essential component of the RNA pol II initiation complex"
    explanation: A dedicated TAF1 review confirming the same molecular role.
  - reference: PMID:29545534
    reference_title: "Zinc knuckle of TAF1 is a DNA binding module critical for TFIID promoter occupancy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Mutation of the TAF1 zinc knuckle with defects in DNA binding compromises promoter occupancy of TFIID, which leads to a decrease in transcription and cell viability."
    explanation: Experimental demonstration that a TAF1 point mutation degrading DNA binding reduces TFIID promoter occupancy and transcription - the closest direct evidence that a TAF1 coding lesion impairs this node's function.
  downstream:
  - target: Impaired Craniofacial Development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      The general transcription defect is presumed to disrupt the craniofacial
      developmental program, the route supported by taf1/taf5 zebrafish
      phenocopy rather than by any measurement in human craniofacial tissue.
    evidence:
    - reference: PMID:37746814
      reference_title: "Deletion of taf1 and taf5 in zebrafish capitulate cardiac and craniofacial abnormalities associated with TAFopathies through perturbations in metabolism."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "The underlying mechanism by which TAFopathies give rise to neurodevelopmental, craniofacial, and cardiac abnormalities remains to be defined."
      explanation: The source states explicitly that the mechanism connecting TAF dysfunction to craniofacial abnormality is undefined, which is what this indirect, unknown-intermediates edge records.
  - target: Dysregulated Neurodevelopmental Transcriptional Program
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Downstream gene sets are shifted in TAF1-lesioned material — genes
      regulated by E-box proteins in a patient family, genes associated with
      neurodevelopmental processes in a taf1-null zebrafish. Neither study
      measured TFIID function itself, so attributing the transcriptional shift
      specifically to impaired TFIID is an inference rather than a measured
      link; the patient study reports the signature as associated with the
      phenotype.
    evidence:
    - reference: PMID:26637982
      reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Functional analysis with RNA-seq for one of the families suggested that the phenotype is associated with downregulation of a set of genes notably enriched with genes regulated by E-box proteins."
      explanation: Patient RNA-seq links the TAF1 lesion to a specific downstream transcriptional signature.
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Transcriptome analysis of taf1 zebrafish knockout revealed enrichment for genes associated with neurodevelopmental processes."
      explanation: An orthogonal, whole-organism demonstration that loss of taf1 dysregulates specifically neurodevelopmental gene sets.
- name: Impaired Craniofacial Development
  role: intermediate
  biological_scale: TISSUE
  description: >
    Loss of TAF/TFIID function disrupts craniofacial development. In zebrafish,
    taf5 nonsense mutation produces craniofacial hypoplasia alongside cardiac
    defects, and CRISPR editing shows the same defects are phenocopied by taf1
    mutation; craniofacial hypoplasia is part of the shared human TAFopathy
    phenotype. This node is the developmental substrate for the recognizable
    facial gestalt, and its direct evidence is from model organisms.
  locations:
  - preferred_term: craniofacial region
    term:
      id: UBERON:0007811
      label: craniocervical region
  evidence:
  - reference: PMID:37746814
    reference_title: "Deletion of taf1 and taf5 in zebrafish capitulate cardiac and craniofacial abnormalities associated with TAFopathies through perturbations in metabolism."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "CRISPR/CAS9 mediated gene editing revealed that these defects where phenocopied by mutations in taf1 and taf5."
    explanation: Establishes that taf1 mutation specifically reproduces the craniofacial and cardiac defect set in a whole organism.
  - reference: PMID:37746814
    reference_title: "Deletion of taf1 and taf5 in zebrafish capitulate cardiac and craniofacial abnormalities associated with TAFopathies through perturbations in metabolism."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Pathogenic variants in components of TATA-binding protein associated factors (TAFs) have recently been identified in a subset of patients with intellectual disability, craniofacial hypoplasia, and congenital heart disease."
    explanation: Places craniofacial involvement in the human TAFopathy phenotype. Graded OTHER as the study's background summary of others' human findings.
  downstream:
  - target: Characteristic facial dysmorphism
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Disrupted craniofacial development is the presumed substrate for the
      recognizable facial gestalt. The developmental evidence is from
      zebrafish; no study traces the human facial features to a specific
      craniofacial developmental step.
    evidence:
    - reference: PMID:37746814
      reference_title: "Deletion of taf1 and taf5 in zebrafish capitulate cardiac and craniofacial abnormalities associated with TAFopathies through perturbations in metabolism."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "we have recovered a recessive mutant phenotype characterized by craniofacial hypoplasia, ventricular hypoplasia, heart failure at 96 h post-fertilization and lethality"
      explanation: Supplies the craniofacial developmental defect in the model; the step to the specific human dysmorphic features is the inference this edge records.
  - target: High palate
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      A high palate is a craniofacial structural finding and is attached to the
      craniofacial developmental node on the same model-derived basis as the
      rest of the gestalt.
    evidence:
    - reference: PMID:37746814
      reference_title: "Deletion of taf1 and taf5 in zebrafish capitulate cardiac and craniofacial abnormalities associated with TAFopathies through perturbations in metabolism."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "CRISPR/CAS9 mediated gene editing revealed that these defects where phenocopied by mutations in taf1 and taf5."
      explanation: The craniofacial defect set in the model is the basis for attaching palatal morphology; the specific human finding is not traced in any study.
- name: Dysregulated Neurodevelopmental Transcriptional Program
  role: intermediate
  biological_scale: MOLECULAR
  description: >
    The transcriptional consequence of impaired TFIID function is
    preferentially felt in neurodevelopmental gene sets. Patient RNA-seq shows
    downregulation of E-box-regulated genes; taf1-null zebrafish transcriptomes
    are enriched for neurodevelopmental genes; and TAF1-deficient neuronal
    cells show differential expression of neuronal ion channel genes.
  biological_processes:
  - preferred_term: regulation of transcription by RNA polymerase II
    term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:26637982
    reference_title: "TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the phenotype is associated with downregulation of a set of genes notably enriched with genes regulated by E-box proteins"
    explanation: Names the specific transcriptional signature observed in a patient family.
  - reference: PMID:32714589
    reference_title: "A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our results showed that neuronal ion channel genes were differentially expressed between TAF1 deletion and TAF1 variant p.Ser1600Gly cells, when compared with their respective controls, and that the TAF1 variant may impair neuronal differentiation and cell proliferation."
    explanation: Shows in a neuronal cell model that both TAF1 deletion and the patient variant shift neuronal gene expression.
  downstream:
  - target: Impaired Neuronal Differentiation and Neurodevelopment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      TAF1-variant neuronal cells show both a shifted expression program and
      impaired differentiation and proliferation, but the two were measured
      separately and the source states the differentiation effect as a
      possibility rather than a demonstrated consequence of the expression
      change.
    evidence:
    - reference: PMID:32714589
      reference_title: "A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: IN_VITRO
      snippet: "the TAF1 variant may impair neuronal differentiation and cell proliferation"
      explanation: Connects the TAF1 variant to the cellular differentiation defect in the hedged terms the source uses; the step from the expression program to differentiation is not itself measured.
- name: Impaired Neuronal Differentiation and Neurodevelopment
  role: intermediate
  biological_scale: CELLULAR
  description: >
    Neuronal differentiation and proliferation are impaired in TAF1-variant
    neuronal cells, and intact taf1 is required for embryonic development with
    knockout transcriptomes enriched for neurodevelopmental processes. This is
    the cellular step through which the transcriptional lesion becomes a
    neurodevelopmental syndrome.
  biological_processes:
  - preferred_term: neuron differentiation
    term:
      id: GO:0030182
      label: neuron differentiation
    modifier: DECREASED
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In conclusion, we propose that functional TAF1 is essential for embryonic development and specifically neurodevelopmental processes."
    explanation: The zebrafish knockout study's conclusion that TAF1 function is specifically required for neurodevelopment.
  - reference: PMID:32714589
    reference_title: "A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "further extends our knowledge of a potential link between TAF1 deficiency and defects in neuronal cell function"
    explanation: States the link between TAF1 deficiency and neuronal cell dysfunction at the hedging level the source supports.
  downstream:
  - target: Global developmental delay
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Impaired neurodevelopment is the presumed route to the clinical
      developmental delay, but no study traces the intervening steps in
      humans.
    evidence:
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "we propose that functional TAF1 is essential for embryonic development and specifically neurodevelopmental processes"
      explanation: Supports neurodevelopmental impairment as the mechanism class behind the clinical delay; the human intermediates are not established, hence the indirect edge.
  - target: Intellectual disability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Intellectual disability is the cognitive endpoint of the impaired
      neurodevelopmental program. The specific neural substrate is not
      established.
    evidence:
    - reference: PMID:31344492
      reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "How these mutations cause dysmorphology, hypotonia, intellectual and motor defects is unknown."
      explanation: The source states plainly that the route from TAF1 mutation to intellectual disability is unknown, which is exactly what this indirect, unknown-intermediates edge records.
  - target: Generalized hypotonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Hypotonia is one of the earliest manifestations of the impaired
      neurodevelopmental program. No study traces it to a specific neural or
      neuromuscular substrate in this disorder.
    evidence:
    - reference: PMID:31344492
      reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: OTHER
      snippet: "How these mutations cause dysmorphology, hypotonia, intellectual and motor defects is unknown."
      explanation: Names hypotonia as one of the disease consequences whose mechanistic route the source states is unknown, which is exactly the claim this edge makes.
  - target: Delayed speech and language development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Speech and language delay follows the same impaired neurodevelopmental
      program as the global delay, without an established specific substrate.
    evidence:
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "we propose that functional TAF1 is essential for embryonic development and specifically neurodevelopmental processes"
      explanation: Supports neurodevelopmental impairment as the mechanism class behind the language delay; the human intermediates are not established.
  - target: Autism spectrum disorder
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Autism spectrum diagnoses arise from the same impaired neurodevelopmental
      program that yields the cognitive phenotype. No study identifies the
      circuit-level substrate.
    evidence:
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "Transcriptome analysis of taf1 zebrafish knockout revealed enrichment for genes associated with neurodevelopmental processes."
      explanation: Supports a neurodevelopmental-program origin for the behavioral phenotype; the specific route is not traced.
  - target: Abnormal brain morphology
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Structural brain abnormalities are a consequence of the impaired
      neurodevelopmental program. They are not universal - brain MRI is normal
      in some affected males.
    evidence:
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "In conclusion, we propose that functional TAF1 is essential for embryonic development and specifically neurodevelopmental processes."
      explanation: Supports impaired neurodevelopment as the origin of structural brain findings; no study links a specific developmental step to the human imaging abnormalities.
  - target: Seizure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Seizures are attached to the neurodevelopmental node as a consequence of
      disordered neuronal development. A candidate contributory mechanism is
      the altered expression of neuronal ion channel genes seen in
      TAF1-variant cells, but that link has not been tested against the
      clinical seizure phenotype.
    evidence:
    - reference: PMID:32714589
      reference_title: "A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: IN_VITRO
      snippet: "Our results showed that neuronal ion channel genes were differentially expressed between TAF1 deletion and TAF1 variant p.Ser1600Gly cells, when compared with their respective controls"
      explanation: Provides the ion-channel expression change that is the plausible substrate for seizures; the study does not connect it to seizures in patients, hence the indirect edge.
  - target: Oral-pharyngeal dysphagia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Oral-pharyngeal dysphagia is grouped with the neurodevelopmental and
      hypotonic features on which it plausibly depends. No study establishes
      the route.
    evidence:
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "revealed additional clinical features, such as oral-pharyngeal dysphagia, a high palate, generalized muscle hypotonia, joint hypermobility, and kyphosis"
      explanation: Documents the dysphagia co-occurring with the hypotonia it is grouped with here; the causal route is not demonstrated.
  - target: Cerebellar Purkinje Cell Loss
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      TAF1 deletion in the developing rat brain produces Purkinje cell
      hypoplasia and loss. Whether the same cellular route operates in human
      MRXS33 is not established.
    hypothesis_groups:
    - cerebellar_purkinje_route
    evidence:
    - reference: PMID:31344492
      reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Deletion of TAF1 lead to a hypoplasia and loss of the Purkinje cells."
      explanation: The rat model provides the cellular observation; species and lesion differences are why the human route stays hypothesis-scoped.
- name: Cerebellar Purkinje Cell Loss
  role: consequence
  biological_scale: CELLULAR
  description: >
    In a CRISPR/Cas9 TAF1-edited rat model, TAF1 deletion causes Purkinje cell
    hypoplasia and loss with reduced CaV3.1 T-type calcium channel expression,
    and abnormal motor symptoms track with the resulting irregular cerebellar
    output. This node is model-derived: no human neuropathology has been
    reported for MRXS33.
  cell_types:
  - preferred_term: cerebellar Purkinje cell
    term:
      id: CL:0000121
      label: Purkinje cell
  locations:
  - preferred_term: cerebellum
    term:
      id: UBERON:0002037
      label: cerebellum
  evidence:
  - reference: PMID:31344492
    reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Deletion of TAF1 lead to a hypoplasia and loss of the Purkinje cells."
    explanation: Reports the Purkinje cell hypoplasia and loss that defines this node.
  - reference: PMID:31344492
    reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Abnormal motor symptoms in TAF1-edited rats were associated with irregular cerebellar output caused by changes in the intrinsic activity of the Purkinje cells due to loss of pre-synaptic CaV3.1."
    explanation: Connects the Purkinje pathology to a motor readout through a specified channel mechanism in the model.
  downstream:
  - target: Cerebellar hypoplasia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Purkinje cell hypoplasia and loss in the TAF1-edited rat is the
      model-derived candidate substrate for the cerebellar hypoplasia reported
      in a TAF1 proband. No human neuropathology exists to confirm that the
      human imaging finding reflects this cellular lesion, and brain MRI is
      normal in affected males from another pedigree.
    hypothesis_groups:
    - cerebellar_purkinje_route
    evidence:
    - reference: PMID:31344492
      reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Deletion of TAF1 lead to a hypoplasia and loss of the Purkinje cells."
      explanation: Supplies the cellular hypoplasia in the model; the bridge to the human imaging finding is what the hypothesis group scopes.
  - target: Gait disturbance
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Cerebellar Purkinje pathology is the model-derived candidate substrate
      for the motor and gait phenotype seen in patients. The evidence for this
      link is entirely from the rat model.
    hypothesis_groups:
    - cerebellar_purkinje_route
    evidence:
    - reference: PMID:31344492
      reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "TAF1-edited rats exhibited behavioral deficits at both the neonatal and juvenile stages of development."
      explanation: Establishes the behavioral/motor consequence in the model; extrapolation to human gait disturbance is what the hypothesis group scopes.

genetic:
- name: TAF1
  gene_term:
    preferred_term: TAF1
    term:
      id: hgnc:11535
      label: TAF1
  relationship_type: CAUSATIVE
  inheritance:
  - name: X-linked recessive
    inheritance_term:
      preferred_term: X-linked recessive inheritance
      term:
        id: HP:0001419
        label: X-linked recessive inheritance
    evidence:
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "we present a five-generation family affected with X-linked intellectual disability that co-segregated with a TAF1 c.3568C>T, p.(Arg1190Cys) variant"
      explanation: Demonstrates X-linked co-segregation of a TAF1 variant with the intellectual disability phenotype.
  notes: >
    TAF1 lies at Xq13.1 and encodes the largest subunit of TFIID, a protein of
    roughly 1,870-1,890 amino acids depending on the isoform and source cited.
    Disease alleles are overwhelmingly missense and are distributed across the
    protein, including the TAF1-TAF7 interaction domain and the tandem
    C-terminal bromodomains. A translation-initiation-codon (start-loss)
    variant, one splice-site variant, and two large Xq13.1 duplications have
    also been reported, so "missense" describes the dominant class rather than
    the whole allelic spectrum. The absence of hemizygous loss-of-function
    alleles in population databases - a statement both sources qualify to the
    canonical protein-coding isoform - together with embryonic lethality of
    null alleles in mouse and zebrafish, indicates that complete loss of TAF1
    is not viable and that disease alleles retain partial function. Assigning pathogenicity to individual TAF1 missense variants is
    difficult: the gene is very large, it is X-linked, and a substantial
    fraction of candidate variants in the largest series could not be confidently
    classified.
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the large size of the gene (1,893 amino acids), and the fact that TATA-box binding protein-associated factor 1 (TAF1) is centrally involved in global RNA polymerase II (pol II) transcription"
    explanation: Gives the size and central transcriptional role that make variant interpretation hard. Note this source's 1,893 figure differs from the 1,873 given by the TAF1 review (PMID:39323550); the notes therefore state a range rather than pick one.
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It also illustrates the challenges for determining the pathogenicity of inherited missense variants, particularly for genes mapping to chromosome X."
    explanation: Records the variant-interpretation difficulty that qualifies every reported TAF1 missense allele.
  - reference: PMID:38804708
    reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The TAF1 gene is located on the X chromosome (Xq13.1); thus, in males, there is only one copy, and in females, there are two, one of which undergoes X inactivation to maintain the same dosage in both sexes"
    explanation: Establishes the chromosomal location and dosage context underlying the X-linked inheritance.
  - reference: PMID:25644381
    reference_title: "X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "potentially deleterious variants in 2 novel candidate XLID genes (CDK16 and TAF1)"
    explanation: The X-exome study that first flagged TAF1 as a candidate X-linked intellectual disability gene.
  variants:
  - name: TAF1 c.3568C>T p.(Arg1190Cys)
    description: >
      Missense variant in the RAP74-interacting domain, co-segregating with
      X-linked intellectual disability across a five-generation family.
    evidence:
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "we present a five-generation family affected with X-linked intellectual disability that co-segregated with a TAF1 c.3568C>T, p.(Arg1190Cys) variant"
      explanation: Reports the variant and its co-segregation with disease.
  - name: TAF1 c.4735A>G p.Ser1600Gly
    description: >
      Missense variant in the second bromodomain identified by combined genome
      and transcriptome sequencing in a proband with cerebellar hypoplasia; the
      carrier mother showed 90:10 skewed X-chromosome inactivation.
    evidence:
    - reference: PMID:32714589
      reference_title: "A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "By combining genome sequence data with transcriptomic data, a probable candidate variant, p.Ser1600Gly, emerged in TAF1."
      explanation: Reports identification of the variant in the proband.
    - reference: PMID:32714589
      reference_title: "A novel variant in TAF1 affects gene expression and is associated with X-linked TAF1 intellectual disability syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "the RNA-seq data revealed a 90:10 extremely skewed X-chromosome inactivation (XCI) in the mother"
      explanation: Documents the skewed XCI in the carrier mother that accompanies this variant.
  - name: TAF1 c.1A>C p.(Met1?)
    description: >
      Translation-initiation-codon variant found in the original Abidi syndrome
      family, whose lymphoblasts show reduced RAP74 phosphorylation.
    evidence:
    - reference: PMID:42548218
      reference_title: "Abidi Syndrome and Another Family With X-Linked Intellectual Disability Have TAF1 Variants and Reduced Phosphorylation of RNA Polymerase II Associated Protein 74."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "A single base substitution that alters the translation initiation codon of TAF1, c.1A>C (p.Met1?), was found in affected males from the original Abidi syndrome family by X-exome sequencing."
      explanation: Reports the variant and the family in which it segregates.
  - name: TAF1 c.4286A>C p.(Gln1429Pro)
    description: >
      C-terminal domain missense variant identified in a second X-linked
      intellectual disability family, also associated with reduced RAP74
      phosphorylation.
    evidence:
    - reference: PMID:42548218
      reference_title: "Abidi Syndrome and Another Family With X-Linked Intellectual Disability Have TAF1 Variants and Reduced Phosphorylation of RNA Polymerase II Associated Protein 74."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "A missense variant in the C-terminal domain of TAF1, c.4286A>C (p.Gln1429Pro), was identified in another XLID family including three males with intellectual disability and variable somatic features using the same approach."
      explanation: Reports the variant and the family in which it was identified.

diagnosis:
- name: Exome or genome sequencing with segregation analysis
  description: >
    Affected males are typically ascertained through exome or genome
    sequencing performed for idiopathic developmental delay or intellectual
    disability. Because TAF1 is large, X-linked, and tolerant of many benign
    missense changes, a candidate variant requires familial segregation
    analysis and clinical phenotyping before pathogenicity can be assigned;
    in the largest series only a minority of candidate variants could be
    confidently classified. Skewed X-chromosome inactivation in the carrier
    mother is a supporting observation.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: NCIT:C19770
      label: Molecular Analysis
  results: >
    Identification of a hemizygous TAF1 variant in an affected male, supported
    by segregation with the phenotype in the family.
  evidence:
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Variants were identified using exome sequencing (ES) or genome sequencing (GS) primarily through clinical diagnostic testing."
    explanation: States the diagnostic modality by which the cohort was ascertained.
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Familial segregation analysis, clinical phenotyping, and bioinformatics were capitalized on to assess potential variant pathogenicity"
    explanation: Describes the interpretive steps required beyond sequencing itself.
  - reference: PMID:31646703
    reference_title: "Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Most individuals were initially referred to clinics for the investigation of idiopathic-DD and/or ID."
    explanation: Records the clinical indication that leads to testing.

- name: Chromosomal microarray for the duplication lesion
  description: >
    Sequencing-based testing will not reliably detect the Xq13.1 duplication
    that constitutes the entry's second trigger lesion, so copy-number testing
    is the complementary diagnostic route. A reported case of floppy infant
    syndrome was resolved by SNP array showing an Xq13.1 duplication spanning
    TAF1 among other genes, with the same duplication carried by the mother and
    grandmother - which also illustrates the X-linked segregation the
    inheritance block describes.
  diagnosis_term:
    preferred_term: chromosomal microarray analysis
    term:
      id: NCIT:C18477
      label: Microarray Analysis
  results: >
    Detection of a copy-number gain at Xq13.1 encompassing TAF1 in a male with
    hypotonia and developmental delay.
  evidence:
  - reference: PMID:30298503
    reference_title: "[Identification of a novel duplication of Xq13.1 in a case with floppy infant syndrome with SNP-array]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Single nucleotide polymorphism array (SNP array) was used for analyzing the whole genome copy number mutations in the proband."
    explanation: Establishes the copy-number testing modality used to detect the duplication.
  - reference: PMID:30298503
    reference_title: "[Identification of a novel duplication of Xq13.1 in a case with floppy infant syndrome with SNP-array]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The multiple PCR-DHPLC assay confirmed duplication of HDAC8, PHKA1, TAF1, DLG3, KIF4A, IGBP1, PJA1 and SLC16A2 genes in the proband."
    explanation: Confirms a TAF1-containing Xq13.1 duplication detected in a hypotonic infant, the lesion class the sequencing-based entry would miss.

treatments:
- name: Supportive and Developmental Care
  description: >
    No disease-modifying therapy exists for TAF1-related disorders. Management
    is supportive and developmental — early intervention, physical, speech, and
    occupational therapies directed at the delay, hypotonia, and gait
    disturbance — together with surveillance for the seizure, hearing, and
    cardiac features documented in the expanded allelic series.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: supportive and developmental care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:38804708
    reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Currently, there are no successful treatments for these TAF1 disorders."
    explanation: Establishes the absence of disease-modifying therapy, which is why management is supportive.
- name: Genetic Counseling
  description: >
    Genetic counseling addresses the X-linked recurrence risk and carrier
    status. Carrier mothers are typically asymptomatic with completely skewed
    X-chromosome inactivation, so a normal maternal phenotype does not exclude
    carrier status; symptomatic female carriers have also been reported.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:31341187
    reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected males presented with intellectual disability and dysmorphic features, while heterozygous females were asymptomatic and had completely skewed X-chromosome inactivation."
    explanation: Establishes the asymptomatic-carrier-female biology that makes counseling and carrier testing necessary; the paper reports the genetics, not the counseling intervention, hence INDIRECT.
  - reference: PMID:38804708
    reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    snippet: "many female cases are asymptomatic and were identified due to their relationship with affected male family members"
    explanation: Confirms that carrier females are found through the family rather than by their own presentation, which is the counseling-relevant point.

animal_models:
- name: Taf1 knockout mouse
  species: Mouse
  genotype: Ubiquitous Taf1 knockout (conditional cre-lox allele)
  publication: PMID:38804708
  description: >
    The first ubiquitous Taf1 knockout mouse, generated from a validated
    conditional cre-lox allele. Deletion is embryonically lethal in males;
    heterozygous females show increased weight and reduced movement but no
    gross brain differences.
  modeled_mechanisms:
  - target: TAF1 Hypomorphic Missense Variants
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    model_scale: ORGANISM
    description: >
      A complete null does not model the human hypomorphic disease lesion:
      male nulls die in utero rather than developing a neurodevelopmental
      syndrome, and heterozygous females escape the lesion through skewed X
      inactivation. The link is pointed at the lesion node rather than at the
      downstream transcription node because a null unquestionably perturbs
      TFIID-dependent transcription — what it fails to reproduce is the
      partial-function allele the human disease actually carries.
    limitations: >-
      Male hemizygous knockout is embryonically lethal, so the genotype that
      corresponds to the human affected male produces no live phenotype to
      compare. Heterozygous females show extreme skewing toward the non-mutant
      chromosome, with no differences in gross brain structure, overall
      expression, or protein localisation, so they do not model the male
      syndrome either. Human disease alleles are missense and hypomorphic, not
      null.
    evidence:
    - reference: PMID:38804708
      reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We discovered that Taf1 deletion in male mice was embryonically lethal, which may explain why no null variants have been identified in humans."
      explanation: The lethality is precisely why this model cannot reproduce the human neurodevelopmental mechanism in the corresponding genotype.
    - reference: PMID:38804708
      reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "In the brains of Taf1 heterozygous female mice, no differences were found in gross structure, overall expression and protein localisation, suggesting extreme skewed X inactivation towards the non-mutant chromosome."
      explanation: The surviving heterozygous genotype shows no brain phenotype, confirming that neither available genotype recapitulates the human mechanism.
    readouts:
    - name: Body weight and locomotor activity in heterozygous females
      target: TAF1 Hypomorphic Missense Variants
      direction: ALTERED
      interpretation: >
        The only phenotype the surviving genotype yields is a weight and
        movement change, interpreted by the authors as a small subset of
        neurons being affected — far short of the human syndrome.
      evidence:
      - reference: PMID:38804708
        reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "these female mice exhibited a significant increase in weight, weight with age, and reduced movement, suggesting that a small subset of neurons was negatively impacted by Taf1 loss"
        explanation: Reports the measured weight and movement changes in heterozygous females.
- name: taf1 knockout zebrafish
  species: Zebrafish
  genotype: Complete taf1 knockout
  publication: PMID:31341187
  description: >
    The first complete knockout of the TAF1 orthologue in zebrafish. The model
    establishes that intact taf1 is required for embryonic development and
    that its loss preferentially dysregulates neurodevelopmental gene sets.
  modeled_mechanisms:
  - target: Dysregulated Neurodevelopmental Transcriptional Program
    relationship: PERTURBS
    fidelity: MODERATE
    model_scale: ORGANISM
    description: >
      Complete loss of taf1 perturbs the transcriptional program and reveals
      enrichment for neurodevelopmental genes, supporting the specificity of
      the transcriptional lesion for neurodevelopment.
    limitations: >-
      A complete null in zebrafish is lethal during embryonic development,
      whereas human disease alleles are hypomorphic missense variants in
      surviving males, so the model perturbs the mechanism rather than
      reproducing the disease state.
    evidence:
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We investigated the role of TAF1 and its association to neurodevelopment by creating the first complete knockout model of the TAF1 orthologue in zebrafish."
      explanation: Establishes the model and its purpose as a perturbation of TAF1 function.
    readouts:
    - name: Neurodevelopmental gene enrichment in knockout transcriptome
      target: Dysregulated Neurodevelopmental Transcriptional Program
      direction: ALTERED
      interpretation: >
        Loss of taf1 shifts the transcriptome specifically toward
        neurodevelopmental gene sets, which is the model's central support for
        the transcriptional node.
      evidence:
      - reference: PMID:31341187
        reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Transcriptome analysis of taf1 zebrafish knockout revealed enrichment for genes associated with neurodevelopmental processes."
        explanation: Reports the transcriptomic measurement behind this readout.
  - target: TAF1 Hypomorphic Missense Variants
    relationship: MEASURES
    fidelity: MODERATE
    model_scale: ORGANISM
    description: >
      The model provides the organismal evidence that complete TAF1 loss is
      not viable, which is the basis for interpreting human disease alleles as
      hypomorphic rather than null.
    limitations: >-
      Embryonic lethality in zebrafish is evidence about the null state, not
      about any specific human missense allele's residual activity.
    evidence:
    - reference: PMID:31341187
      reference_title: "TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "A crucial function of human TAF1 during embryogenesis can be inferred from the model, demonstrating that intact taf1 is essential for embryonic development."
      explanation: Supplies the essentiality result that constrains the human allelic spectrum to hypomorphs.
- name: CRISPR/Cas9 TAF1-edited rat
  species: Rat
  genotype: Somatic brain TAF1 deletion by lentiviral CRISPR/Cas9 (gRNA-TAF1, intracerebroventricular)
  publication: PMID:31344492
  description: >
    A somatic brain transgenesis model in which TAF1 is deleted in the
    postnatal rat brain by intracerebroventricular delivery of lentiviral
    CRISPR/Cas9. It was developed specifically because embryonic mouse
    knockouts of TAF1 had failed, and it produces behavioral deficits with
    cerebellar Purkinje cell pathology.
  modeled_mechanisms:
  - target: Cerebellar Purkinje Cell Loss
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: TISSUE
    description: >
      TAF1 deletion in the developing rat brain produces Purkinje cell
      hypoplasia and loss with reduced CaV3.1 expression and associated motor
      deficits — the observations that define this node.
    limitations: >-
      The lesion is a somatic postnatal deletion delivered to part of the
      brain, not a germline hypomorphic missense allele present from
      conception, and no human MRXS33 neuropathology exists against which to
      check the Purkinje finding.
    evidence:
    - reference: PMID:31344492
      reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Here, we report the development and characterization of a novel animal model for TAF1 ID syndrome in which the TAF1 gene is deleted in embryonic rats using clustered regularly interspaced short palindromic repeats (CRISPR) associated protein 9 (Cas9) technology and somatic brain transgenesis mediated by lentiviral transduction."
      explanation: Establishes the model as purpose-built for TAF1 ID syndrome, supporting its use as informative for this node.
    readouts:
    - name: Purkinje cell number and cerebellar morphology
      target: Cerebellar Purkinje Cell Loss
      direction: DECREASED
      interpretation: Direct histopathological correlate of the Purkinje cell loss node.
      evidence:
      - reference: PMID:31344492
        reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Deletion of TAF1 lead to a hypoplasia and loss of the Purkinje cells."
        explanation: Reports the histological measurement behind this readout.
    - name: CaV3.1 T-type calcium channel expression
      target: Cerebellar Purkinje Cell Loss
      direction: DECREASED
      interpretation: >
        Reduced presynaptic CaV3.1 is the channel-level change the authors link
        to irregular cerebellar output in this model.
      evidence:
      - reference: PMID:31344492
        reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Immunostaining revealed a reduction in the expression of the CaV3.1 T-type calcium channel."
        explanation: Reports the immunostaining measurement behind this readout.
    - name: Behavioral response to the T-type calcium channel enhancer SAK3
      target: Cerebellar Purkinje Cell Loss
      direction: RESTORED
      interpretation: >
        Pharmacological rescue in the same model. SAK3 is a preclinical tool
        compound in rats; it is not a treatment for the human disease and is
        deliberately not curated in the treatments section.
      evidence:
      - reference: PMID:32622085
        reference_title: "The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Oral administration of SAK3 (0.25 mg/kg, p.o.) significantly rescued the behavior abnormalities in beam walking test and open field test caused by TAF1 gene editing."
        explanation: Reports the behavioral rescue measurement in the TAF1-edited rat.
      - reference: PMID:32622085
        reference_title: "The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "SAK3 protected the Purkinje and granule cells from apoptosis induced by TAF-1 gene editing."
        explanation: Ties the rescue specifically to the Purkinje cell population this node names.
    - name: Cortical neuron and astrocyte survival under SAK3
      target: Cerebellar Purkinje Cell Loss
      direction: RESTORED
      interpretation: >
        The same compound protects cortical neurons and astrocytes and restores
        BDNF/AKT/GSK3-beta signaling, indicating the rescue is not confined to
        the cerebellum. Recorded here because the companion study shares the
        model; it is a preclinical rat result, not a human therapy.
      evidence:
      - reference: PMID:33359140
        reference_title: "Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "SAK3 treatment prevented the loss of cortical neurons and GFAP-positive astrocytes observed after TAF1 gene editing."
        explanation: Reports the cortical neuron and astrocyte protection measurement in the same TAF1-edited rat model.
      - reference: PMID:33359140
        reference_title: "Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "SAK3 also restored the Brain-derived neurotrophic factor/protein kinase B/Glycogen Synthase Kinase 3 Beta (BDNF/AKT/GSK3β) signaling axis in TAF1 edited animals."
        explanation: Reports the signaling-axis readout accompanying the cellular rescue.

differential_diagnoses:
- name: X-linked dystonia-parkinsonism
  description: >
    The other TAF1 disease, and the key allelic differential. XDP is caused by
    a Filipino founder SINE-VNTR-Alu retrotransposon insertion in intron 32 of
    TAF1 — a non-coding lesion — and presents in adulthood as a progressive
    dystonia-parkinsonism with neostriatal degeneration. MRXS33 is caused by
    coding missense variants (or Xq13.1 duplication) and presents congenitally
    as a neurodevelopmental syndrome. Both are X-linked and both involve TAF1
    transcriptional dysregulation, so gene-level testing alone does not
    distinguish them; the lesion class does.
  disease_term:
    preferred_term: X-linked dystonia-parkinsonism
    term:
      id: MONDO:0010747
      label: X-linked dystonia-parkinsonism
  distinguishing_features:
  - Lesion class - intronic SVA retrotransposon insertion in XDP versus coding missense variant or Xq13.1 duplication in MRXS33
  - Age at onset - adult in XDP versus congenital/infantile in MRXS33
  - Filipino founder ancestry with a single shared haplotype in XDP
  - Progressive movement disorder with neostriatal degeneration in XDP versus developmental delay with facial dysmorphism in MRXS33
  evidence:
  - reference: PMID:38804708
    reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "TAF1 missense variants in human males cause X-linked intellectual disability, a neurodevelopmental disorder, and TAF1 is dysregulated in X-linked dystonia-parkinsonism, a neurodegenerative disorder."
    explanation: States the allelic relationship and the neurodevelopmental versus neurodegenerative contrast that separates the two entities.
  - reference: PMID:32622085
    reference_title: "The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "A non-coding 2.6 kb insertion of a SINE-VNTR-Alu (SVA)-type retrotransposon in intron 32 of TAF1 causes the neurological disorder X-linked dystonia-parkinsonism (XDP; OMIM: 313650). XDP is a progressive neurodegenerative disorder characterized by involuntary movements (dystonia), most often developing in adult life in combination with Parkinsonism"
    explanation: Specifies the distinct XDP lesion and its adult-onset movement-disorder presentation.
- name: TAF-subunit TAFopathies
  description: >
    Pathogenic variants in other components of the TAF/TFIID complex — TBP,
    TAF2, and TAF6 — produce an overlapping syndrome of intellectual
    disability with craniofacial and cardiac anomalies, collectively termed
    TAFopathy. These share the general-transcription-machinery mechanism with
    TAF1 disease and overlap clinically, so the differential is resolved by
    which subunit carries the variant rather than by phenotype.
  distinguishing_features:
  - Which TFIID subunit carries the variant on sequencing
  - TAF1 disease is X-linked and male-limited in practice, whereas the other TAFopathies are autosomal
  evidence:
  - reference: PMID:37746814
    reference_title: "Deletion of taf1 and taf5 in zebrafish capitulate cardiac and craniofacial abnormalities associated with TAFopathies through perturbations in metabolism."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "This syndrome has been termed as a TAFopathy and includes mutations in TATA binding protein (TBP), TAF1, TAF2, and TAF6."
    explanation: Names the TAFopathy group and its member genes, establishing the differential. Graded OTHER because this is the zebrafish study's background framing rather than its own human data.

mechanistic_hypotheses:
- hypothesis_group_id: rap74_phosphorylation_route
  hypothesis_label: Reduced RAP74 phosphorylation as the route from TAF1 variant to transcriptional dysfunction
  status: EMERGING
  description: >
    Patient lymphoblasts carrying two independent pathogenic TAF1 variants show
    reduced phosphorylation of RAP74. The authors advance this as a potential
    mechanism connecting the variants to transcriptional dysfunction. Two
    things keep it a hypothesis rather than a curated step. No study has shown
    the phosphorylation deficit is necessary or sufficient for the
    neurodevelopmental phenotype; and the mechanism the authors propose depends
    on TAF1 itself being the kinase, an activity a 2024 review reports could
    not be confirmed in recent TFIID/TAF1 studies, with much of the original
    work retracted. The measured phosphorylation change stands; its attribution
    to a TAF1 kinase activity does not.
  evidence:
  - reference: PMID:42548218
    reference_title: "Abidi Syndrome and Another Family With X-Linked Intellectual Disability Have TAF1 Variants and Reduced Phosphorylation of RNA Polymerase II Associated Protein 74."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "This study expands the phenotypic spectrum of TAF1-related XLID and implicates reduced RAP74 phosphorylation as a potential mechanism."
    explanation: The source's own framing as a potential mechanism is what this hypothesis group records.
  - reference: PMID:39323550
    reference_title: "The roles of TAF1 in neuroscience and beyond."
    supports: REFUTE
    evidence_source: OTHER
    snippet: "These studies could not be reproduced by others and much of the related work by Sauer et al. has been retracted"
    explanation: Undercuts the kinase premise the proposed mechanism rests on, which is why this group is EMERGING rather than a curated causal step.
- hypothesis_group_id: cerebellar_purkinje_route
  hypothesis_label: Cerebellar Purkinje cell loss as the substrate of the motor phenotype
  status: EMERGING
  description: >
    A CRISPR-edited rat model shows that TAF1 deletion in the developing brain
    causes Purkinje cell hypoplasia and loss with reduced CaV3.1 expression,
    and that pharmacological enhancement of T-type calcium channels rescues
    both the cells and the behavior. Whether cerebellar Purkinje pathology is
    the substrate of gait disturbance in human MRXS33 is untested: no human
    neuropathology has been reported, and brain MRI is normal in some affected
    males.
  evidence:
  - reference: PMID:31344492
    reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Abnormal motor symptoms in TAF1-edited rats were associated with irregular cerebellar output caused by changes in the intrinsic activity of the Purkinje cells due to loss of pre-synaptic CaV3.1."
    explanation: Supplies the model-level mechanism the hypothesis proposes to extend to humans.
  - reference: PMID:31344492
    reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "How these mutations cause dysmorphology, hypotonia, intellectual and motor defects is unknown."
    explanation: The same paper states that the route from mutation to motor defect is unknown, which is why this remains a hypothesis rather than a curated causal chain.

discussions:
- discussion_id: taf1_models_are_null_human_disease_is_hypomorphic
  kind: HUMAN_MODEL_MISMATCH
  prompt: >
    Every TAF1 animal model uses a null or somatic-deletion lesion, while human
    MRXS33 is caused by germline hypomorphic missense variants. Does any
    existing model report on the mechanism of the human missense disease?
  attaches_to:
  - pathophysiology#TAF1 Hypomorphic Missense Variants
  - pathophysiology#Cerebellar Purkinje Cell Loss
  rationale: >
    The mismatch is structural, not incidental. Complete TAF1 loss is
    embryonically lethal in both mouse and zebrafish, so the genotype that
    corresponds to an affected human male cannot be studied in those systems at
    all; the rat model circumvents lethality only by deleting TAF1 somatically
    in the postnatal brain, which is a different lesion in a different
    developmental window. Consequently the cerebellar Purkinje pathology that
    the rat model contributes — the entry's only cellular account of the motor
    phenotype — rests on a lesion class the human disease does not have, and no
    human neuropathology exists to check it against. Brain MRI is reported
    normal in at least one affected male, which is at least consistent with the
    cerebellar route not being universal.
  evidence:
  - reference: PMID:31344492
    reference_title: "TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Mouse models which have embryonically targeted TAF1 have failed, possibly due to TAF1 being essential for viability, preferentially expressed in early brain development, and intolerant of mutation."
    explanation: States why germline mammalian models of TAF1 are unavailable, which is the origin of the mismatch.
  - reference: PMID:38804708
    reference_title: "Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We discovered that Taf1 deletion in male mice was embryonically lethal, which may explain why no null variants have been identified in humans."
    explanation: Confirms the lethality of the null genotype in the mammalian model, closing off the direct comparison to affected human males.

notes: >
  Curation scope decisions. No `conforms_to` module target was declared. The
  closest candidate, `epigenetic_machinery_neurodevelopmental_dysregulation`,
  explicitly scopes itself to the machinery that maintains chromatin state
  (writers, erasers, remodelers, readers) and excludes transcriptional lesions
  that are not chromatin-machinery lesions. TAF1 is a subunit of the general
  transcription factor TFIID acting at the RNA polymerase II preinitiation
  complex, and the literature groups it with the TAFopathies (TBP, TAF1, TAF2,
  TAF6) rather than with the chromatinopathies. No TFIID or
  general-transcription-machinery module exists in `kb/modules/` at the time of
  writing; one covering the TAFopathies would be the natural home for this
  mechanism.

  SAK3, a T-type calcium channel enhancer that rescues behavior and Purkinje
  cell survival in the TAF1-edited rat, is deliberately curated as a readout on
  that animal model rather than as a `treatments` entry. It has been tested only
  in rats and is not a human therapy.

  No GeneReviews chapter exists for TAF1 intellectual disability syndrome. A
  PubMed search for TAF1 plus GeneReviews returns only the X-linked
  dystonia-parkinsonism chapter (PMID:20301662), which covers the allelic XDP
  disorder and not MRXS33, so no GeneReviews phenotype baseline was available
  for this entry. Note that `just tag-references` auto-inserted that XDP
  chapter into this entry's top-level `references:` block during curation; it
  was removed, because this entry cites it nowhere and it describes a different
  disease. Do not re-add it on a later tagging sweep.

  One frequently cited case report, PMID:30805980 (Okamoto et al., male
  siblings with a novel TAF1 mutation), was fetched but its cache carries no
  retrievable body text, so no snippet could be quoted from it and it is not
  cited here.

  Phenotypes deliberately left unattached to the pathograph. Hearing
  impairment, Strabismus, Sacral dimple, Joint hypermobility, and Genitourinary
  anomaly have no incoming causal edge. Each is reported only as an
  associated clinical finding in a case series, with no study proposing a
  mechanism that connects it to any node curated here, and the craniofacial and
  neurodevelopmental nodes that carry the rest of the phenotypes do not
  plausibly explain them. An edge drawn from those nodes would be invented
  rather than sourced, so they are left as isolated findings and recorded here.
  The sacral dimple is worth a second look by anyone extending this entry -
  it names the syndrome in one of its Orphanet-style synonyms
  ("sacral caudal remnant"), which suggests a developmental origin nobody has
  yet written down.

  Known gaps left for a follow-up round, recorded so they are not mistaken for
  oversights. Hypoplasia of the corpus callosum, microcephaly, and chronic
  otitis media are reported at appreciable frequency across the published
  series but are curated here only through the general "Abnormal brain
  morphology" phenotype or not at all; each needs its own phenotype entry with
  a quotable frequency. The congenital heart malformation frequency band is
  left as OCCASIONAL on the strength of the "less common features" sentence,
  but a dedicated study (PMID:32396742, Morton et al., congenital heart defects
  due to TAF1 missense variants) reports a much higher proportion in
  damaging-missense carriers; that cache has no retrievable body text, so the
  conflict is recorded here rather than resolved. Treatments are curated as a
  single supportive-care entry plus genetic counseling; the component
  interventions (cardiac repair, antiseizure medication, hearing and strabismus
  management, feeding therapy) are not individually sourced. No treatment
  carries target_mechanisms, so treatments do not join the pathograph.
📚

References & Deep Research

References

2
PMID:26637982
TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations.
No top-level findings curated for this source.
PMID:31646703
Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity.
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: intellectual disability, X-linked, syndromic 33 · 2026-09-05T19:07:21Z · View source

New entry for MRXS33 / TAF1 intellectual disability syndrome (MONDO:0010500), curated for issue 11067. Deep research: Edison (falcon) was requested but its account returned HTTP 402 out of credits, so the run used the documented --fallback path and claude_code produced the report, recorded in research/Intellectual_Disability_X-linked_Syndromic_33-deep-research-claude_code.md with fell_back: true and requested_provider: falcon. The report was used as leads only; every evidence snippet was taken from a reference fetched directly into references_cache and verified against it. preflight-dr against MONDO:0010500 returned WARN only because the HPO 'HP:' prefix is counted as the haptoglobin gene, and because the report mentions OMIM 314250 (XDP), which the entry deliberately discusses as the allelic differential. Gene-drift check: TAF1 mentioned in 44 lines / 57 occurrences with no competing gene. Content: 8 pathophysiology nodes forming a chain from TAF1 hypomorphic missense variants and Xq13.1 duplication through TFIID-dependent transcription dysfunction to impaired neurodevelopment and model-derived cerebellar Purkinje cell loss; 23 phenotypes bound to HP terms; genetic block with four named TAF1 variants; X-linked recessive inheritance bound to HP:0001419; structured prevalence as CASES_IN_LITERATURE / ULTRA_RARE; three animal models (mouse KO as FAILS_TO_RECAPITULATE, zebrafish KO, CRISPR-edited rat) with readouts; two mechanistic hypotheses; a HUMAN_MODEL_MISMATCH discussion; and differential diagnoses positioning MRXS33 against X-linked dystonia-parkinsonism and the other TAFopathies. A pre-PR red-team review in a subagent found that the 2024 TAF1 review already cited by the entry reports TAF1's kinase activity as unreproduced and largely retracted; the RAP74 node was rewritten to curate the measured phosphorylation change rather than assert a TAF1 kinase activity, the GO:0004674 binding was dropped, and REFUTE evidence was added. Three DIRECT causal edges were downgraded to INDIRECT_UNKNOWN_INTERMEDIATES where sources state association or possibility, two modifiers changed to DYSREGULATED, four background statements in animal-model papers regraded from HUMAN_CLINICAL to OTHER, and the mouse-KO FAILS_TO_RECAPITULATE link retargeted to the lesion node. No conforms_to was declared: TAF1 is a general transcription factor and the closest module scopes itself to chromatin machinery. Validation: just validate passes with 102/102 snippets verified, validate-terms passes, and check-folded-hyphens, check-snippet-length, check-title-snippets, check-snippet-grading, check-reference-titles, check-duplicate-keys, check-entity-refs, check-causal-targets, check-qualifier-terms and check-enum-values all pass.

Claude Code ▸
1. Disease Information
claude-fable-5[1m], claude-haiku-4-5-20251001 13 citations 2026-09-04T20:47:57.720993

1. Disease Information

Overview. X-linked syndromic intellectual developmental disorder-33 (MRXS33), also called TAF1 intellectual disability syndrome or TAF1 syndrome, is an ultra-rare X-linked recessive neurodevelopmental disorder caused by hemizygous mutation of TAF1 (TATA-box binding protein associated factor 1) at Xq13.1. Affected males show global developmental delay evolving into intellectual disability, generalized hypotonia, characteristic facial dysmorphism, a highly distinctive gluteal crease anomaly with sacral caudal remnant, variable neurologic features (hearing loss, strabismus, corpus callosum hypoplasia, seizures), and — in about half of individuals with damaging missense variants — congenital heart defects. The founding description is O'Rawe et al. 2015: "We describe an X-linked genetic syndrome associated with mutations in TAF1 and manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features" (PMID:26637982, Am J Hum Genet, doi:10.1016/j.ajhg.2015.11.005).

Identifiers. | Resource | ID | |---|---| | OMIM (phenotype) | #300966 — INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 33; MRXS33 (omim.org/entry/300966) | | MONDO | MONDO:0010500 — "intellectual disability, X-linked, syndromic 33" (verified via OLS this session) | | OMIM (gene) | 313650 (TAF1) | | UMLS / GTR | C4225418 (GTR condition page) | | Orphanet | No dedicated ORPHA entry found (falls under non-specific syndromic ID groupings; searched this session) | | ICD-10/ICD-11 | No disease-specific code; coded under intellectual disability (F70–F79 / 6A00) plus malformation codes |

Synonyms. MRXS33; TAF1 syndrome; TAF1/MRXS33 intellectual disability syndrome; TAF1-related neurodevelopmental disorder. Note: Abidi syndrome (historically a distinct XLID lumped at Xq12-q21) was recently shown to be TAF1-related — Han et al. 2026 found segregating TAF1 variants in the original Abidi syndrome family with functional impact (PMID:42548218).

Data derivation. All knowledge is aggregated from case series and family reports (~50–70 families cumulatively across O'Rawe 2015 [11 families], Cheng 2019 [27 additional families], Morton 2020 [26 individuals with damaging missense variants], plus single-family reports). No registry, EHR-derived cohort, or natural history study exists.

2. Etiology

Causal factor: monogenic. Hemizygous TAF1 variants in males: missense SNVs (the large majority), rare splice-site variants, a start-loss (p.Met1?, Abidi syndrome family; PMID:42548218), and ~0.42 Mb Xq13.1 duplications encompassing TAF1 (two families in O'Rawe 2015; these produce phenotypic overlap "but they also demonstrated a severe neurodegeneration phenotype"; PMID:26637982). No null (complete loss-of-function) hemizygous variants have been reported in living males; mouse data suggest nullizygosity is embryonic-lethal: "We discovered that Taf1 deletion in male mice was embryonically lethal, which may explain why no null variants have been identified in humans" (Crombie et al. 2024, Dis Model Mech; PMID:38804708).

Genetic risk factors. Being male and hemizygous; having a carrier mother (roughly half of reported variants are maternally inherited, half de novo — Morton 2020 found 14 de novo vs 12 maternally inherited damaging missense variants; PMID:32396742). Modifier genes: none identified. Susceptibility loci: none (fully penetrant Mendelian in males, so far as reported).

Environmental risk/protective factors. None known; no environmental contribution to causation has been reported. Protective factor (females): skewed X-chromosome inactivation silencing the mutant allele protects heterozygous carriers — "female carriers of TAF1 mutations and duplications demonstrate highly skewed inactivation (99:1)" (O'Rawe 2015 full text, PMID:26637982); conversely, extreme skewing toward the mutant allele can produce affected females (Vianna 2020: "XLID-potentially related variants were identified in five patients with extreme XCI skewing, including four single nucleotide variants in NLGN4X, HDAC8, TAF1, and USP9X genes"; PMID:32564284).

Gene–environment interaction. None documented.

3. Phenotypes

Frequencies below are from the founding 14-proband series (O'Rawe 2015 full text; PMID:26637982) unless noted; Cheng 2019 (PMID:31646703) added "brain morphological abnormalities, seizures, hearing loss, and heart malformations" as "prominent among previously unreported effects." Suggested HP terms need OLS verification before binding.

Phenotype Type Freq (O'Rawe) Onset / course HP suggestion
Global developmental delay clinical sign 14/14 infancy; static → ID HP:0001263
Intellectual disability clinical sign 14/14 childhood; lifelong, largely stable HP:0001249
Delayed speech and language clinical sign 13/14 early childhood HP:0000750
Generalized hypotonia sign 13/14 neonatal/infantile HP:0001290 (generalized hypotonia)
Unusual gluteal crease with sacral caudal remnant / sacral dimple physical 12/14 congenital; "spine MRI showed no major underlying defects" HP:0000960 (sacral dimple); no precise HP for caudal remnant — keep free-text preferred_term
Oral-pharyngeal dysphagia sign 11/14 infancy HP:0200136 (oral-pharyngeal dysphagia)
Hypoplasia of corpus callosum (MRI) imaging 11/14 congenital HP:0002079
Hearing impairment sensory 10/14 childhood HP:0000365
Strabismus sign 10/14 childhood HP:0000486
Microcephaly physical 10/14 congenital/postnatal HP:0000252
Joint hypermobility sign 10/14 childhood HP:0001382
Autistic behaviors / ASD behavioral 10/14 childhood HP:0000729
Chronic otitis media sign 9/14 childhood, recurrent HP:0000389
Facial gestalt: prominent supraorbital ridges, downslanted palpebral fissures, deep-set eyes, sagging cheeks, long philtrum, low-set protruding ears, long face, high palate, pointed chin, anteverted nares physical majority congenital HP:0000336, HP:0000494, HP:0000490, HP:0000343, HP:0000369/HP:0000411, HP:0000276, HP:0000218, HP:0000307, HP:0000463
Intrauterine and/or postnatal growth retardation physical "most" (OMIM description) prenatal/infancy HP:0001511, HP:0008897
Seizures sign subset (Cheng 2019) variable HP:0001250
Congenital heart defects (ASD, VSD, coarctation, pulmonary stenosis, tetralogy of Fallot) physical 50% (13/26) of damaging-missense carriers (Morton 2020) congenital HP:0001631, HP:0001629, HP:0001680, HP:0001642, HP:0001636
Spastic diplegia, dystonic movements, tremor sign variable/subset childhood HP:0001264, HP:0001332, HP:0001337
Cerebellar hypoplasia imaging single cases (Hurst 2018) congenital HP:0001321
Progressive neurodegeneration, death from cardiopulmonary insufficiency course duplication families only childhood, progressive —

Quality of life. No formal QoL instrument (EQ-5D/PROMIS) study exists. Functionally dominant burdens: communication impairment (speech delay near-universal), feeding difficulty in infancy (dysphagia in ~79%), conductive/sensorineural hearing loss requiring intervention, and lifelong support needs from ID. This is a gap to record as such.

4. Genetic/Molecular Information

Gene. TAF1 — TATA-box binding protein associated factor 1; HGNC:11535 (dismech form hgnc:11535); Xq13.1; NCBI Gene 6872; Ensembl ENSG00000147133; UniProt P21675; OMIM gene 313650 (verified via HGNC REST this session). Encodes the largest subunit (1,873 aa, ~250 kDa) of the general transcription factor TFIID complex (Crombie review, PMID:39323550).

Pathogenic variants. From O'Rawe 2015 (numbering per that paper's transcript): p.Ile1337Thr (maternal), p.Cys807Arg (de novo), p.Arg1246Trp (de novo), p.Ile505Asn (de novo), a splice variant producing p.Arg1228Ilefs*16 (maternal), p.Asn1517His (de novo), p.Arg1431His (de novo), p.Pro596Ser (maternal), p.Asp976His (de novo), plus two ~0.42 Mb Xq13.1 duplications (PMID:26637982). Caution on numbering: ClinVar records the same missense variants under NM_004606.5 with shifted residue numbers (e.g., p.Ile1317Thr, RCV000203524; p.Arg1226Trp, RCV000203515; p.Lys1556Glu, RCV001027762) — a curation trap; always anchor to a stated transcript. Cheng 2019 added 27 families of largely missense variants and emphasized "the challenges for determining the pathogenicity of inherited missense variants, particularly for genes mapping to chromosome X" (PMID:31646703). Han 2026 added p.Met1? and p.Gln1429Pro (Abidi syndrome and a second XLID family; PMID:42548218). Li 2024 reported c.2233T>G segregating in a Chinese XLID pedigree (PMID:38684296). Recurrent site: p.Arg1170Cys "has been reported in four separate XLID studies" (Crombie review, PMID:39323550).

  • Classification: ClinVar holds pathogenic/likely pathogenic and VUS assertions; many inherited missense variants remain contested (the central theme of PMID:31646703).
  • Variant classes: missense ≫ splice-site > start-loss; duplications (CNV); no truncating/null variants in males — consistent with essentiality (PMID:38804708).
  • Origin: germline; de novo and maternally inherited in roughly equal measure (PMID:32396742). Somatic TAF1 mutations occur in cancers (e.g., gastric/colorectal frameshifts, PMID:27571988) but are unrelated to MRXS33.
  • Population frequency: pathogenic variants absent/ultra-rare in gnomAD; gene is strongly constrained against LoF (inferred; verify constraint metrics at gnomAD during curation).
  • Functional consequence: partial loss of function / hypomorphic missense effects on TFIID assembly and partner binding (TAF7-interface variants p.Cys807Arg, p.Pro596Ser, p.Asp976His, p.Arg1246Trp "map to conserved domains critical for TAF1–TAF7 binding"; p.Cys807Arg "would destabilize the triple-barrel fold" — O'Rawe full text). Duplications act by dosage increase with a distinct, degenerative phenotype.

Modifier genes. None known. Epigenetics. X-inactivation state is the decisive epigenetic modifier in females (99:1 skewing in asymptomatic carriers, PMID:26637982; 90:10 skew detected by RNA-seq in a carrier mother, PMID:32714589). Chromosomal abnormalities. The Xq13.1 microduplications above; detectable by CMA/DECIPHER.

Allelic but distinct disorder. X-linked dystonia-parkinsonism (XDP/DYT3, OMIM 314250) is caused not by coding variants but by a ~2.6 kb SVA-F retrotransposon insertion in TAF1 intron 32, whose (CCCTCT)n hexameric repeat length inversely correlates with age of onset (Bragg 2017, PNAS; PMID:29229810). Keep XDP as a separate disease entry; it is mechanistic context, not MRXS33.

5. Environmental Information

Not applicable: no environmental, lifestyle, or infectious contributors to causation are documented for this Mendelian disorder. (Record as an explicit negative in the KB rather than leaving blank.)

6. Mechanism / Pathophysiology

Causal chain (numbered; inferential steps flagged):

  1. Hemizygous TAF1 missense/splice variant (or Xq13.1 duplication) leads to altered TAF1 protein function or dosage — demonstrated at the structural level for TAF7-interface and bromodomain residues (PMID:26637982; PMID:39323550).
  2. Altered TAF1 results in impaired TFIID scaffold assembly/promoter engagement and dysregulated RNA polymerase II transcription initiation — TAF1 "functions as a scaffold, contributing to the assembly and maintaining the structural integrity of TFIID" (PMID:39323550); reduced RAP74 (GTF2F1) phosphorylation in patient lymphoblasts (PMID:42548218) supports a general-transcription-machinery defect (mechanistic step partly inferred; the once-reported intrinsic kinase/HAT/ubiquitination activities of TAF1 "could not be reproduced by others and much of the related work…has been retracted" — PMID:39323550).
  3. Transcriptional dysregulation leads to downregulation of specific neurodevelopmental gene programs — patient RNA-seq showed 213 differentially expressed genes (179 down), with "a significant enrichment of genes regulated by E-box proteins" (PMID:26637982); zebrafish knockout transcriptomes were "enriched for genes associated with neurodevelopmental processes" (PMID:31341187); patient-variant cells showed differential expression of "neuronal ion channel genes" and "the TAF1 variant may impair neuronal differentiation and cell proliferation" (PMID:32714589).
  4. Disrupted neurodevelopmental transcription results in abnormal brain development — microcephaly, corpus callosum hypoplasia, cerebellar hypoplasia in patients (PMID:26637982; PMID:32714589); in rat, "Deletion of TAF1 lead to a hypoplasia and loss of the Purkinje cells" with "loss of pre-synaptic CaV3.1" T-type calcium channels driving "irregular cerebellar output" (PMID:31344492) (model-organism evidence; human confirmation at circuit level absent — a HUMAN_MODEL_MISMATCH candidate).
  5. Abnormal brain development and neuronal dysfunction lead to the clinical phenotype: global developmental delay → intellectual disability ± ASD, hypotonia, motor abnormalities (PMID:26637982; PMID:31646703).
  6. Branch (cardiac): the same transcriptional insufficiency in cardiogenesis results in congenital heart defects in ~50% of damaging-missense carriers (PMID:32396742); supported by zebrafish taf1/taf5 mutants phenocopying "cardiac and craniofacial abnormalities…through perturbations in metabolism" (PMID:37746814) and by TAF1 bromodomain inhibition in cardiomyocytes altering mitochondrial/proliferation/differentiation gene programs (PMID:36958711).
  7. Branch (dosage-increase): TAF1 duplication leads to a severe, progressive neurodegenerative course rather than static ID (PMID:26637982) — direction of dosage effect matters; mechanism unknown.
  8. Downstream signaling correlate (model-only, inferred): TAF1 loss in rat results in depressed BDNF/AKT/GSK3β signaling; the T-type channel enhancer SAK3 "restored the Brain-derived neurotrophic factor/protein kinase B/Glycogen Synthase Kinase 3 Beta (BDNF/AKT/GSK3β) signaling axis" (PMID:33359140).

Annotations for curation: TFIID complex (GO:0005669, suggest); RNA Pol II transcription initiation (GO:0006367, suggest); TBP binding via TAND domain; double bromodomain reading of acetylated histones ("acetylated, butyrylated and crotonylated lysines", PMID:39323550); zinc-knuckle DNA binding for promoter occupancy (PMID:29545534). Cell types: Purkinje cell (CL:0000121, suggest), cardiomyocyte, neural progenitors. Biological scale: MOLECULAR (TFIID dysfunction) → CELLULAR (impaired neuronal differentiation) → TISSUE (CC/cerebellar hypoplasia, septal defects) → ORGANISM (ID, CHD).

7. Anatomical Structures Affected

  • Primary: brain (UBERON:0000955) — cerebral cortex, corpus callosum (UBERON:0002336), cerebellum (UBERON:0002037; Purkinje layer in models).
  • Cardiac: heart (UBERON:0000948) — atrial/ventricular septa, outflow tract (ToF, coarctation, pulmonic stenosis) (PMID:32396742).
  • Craniofacial skeleton and ears: facial dysmorphism; middle ear (chronic otitis media); cochlea/auditory pathway (hearing impairment).
  • Musculoskeletal/other: generalized skeletal muscle hypotonia, joints (hypermobility), sacrococcygeal region (gluteal crease anomaly/sacral caudal remnant), oropharynx (dysphagia), eyes (strabismus, deep-set eyes).
  • Subcellular: nucleus — TFIID at RNA Pol II core promoters (GO:0005634 / GO:0005669, suggest).
  • Lateralization: findings are bilateral/midline; no lateralized pattern reported.

8. Temporal Development

  • Onset: congenital/infantile. IUGR in a subset; hypotonia and feeding difficulty neonatally; developmental delay evident in the first year; per Cheng 2019 the syndrome "present[s] early in life with hypotonia, facial dysmorphia, and developmental delay that evolved into intellectual disability (ID) and/or autism spectrum disorder (ASD)" (PMID:31646703).
  • Progression: for SNV cases, largely static ID (non-degenerative); motor milestones delayed but attained variably. Exception: Xq13.1 duplication cases show "severe and progressive neurodegeneration" (PMID:26637982).
  • Course pattern: chronic lifelong; seizures episodic in the affected subset.
  • Critical periods: embryonic (cardiogenesis; CHD is congenital) and early postnatal neurodevelopment — in rat, Taf1 knockdown at P0 produced "a stronger phenotype…compared with at three weeks after birth" (model evidence; PMID:39323550 review of AAV-miRNA work), suggesting an early postnatal vulnerability window.
  • Remission: not applicable.

9. Inheritance and Population

  • Prevalence/incidence: unknown; ultra-rare. Cumulative literature ≈ 50–70 families worldwide (11 families PMID:26637982; +27 families PMID:31646703; 26 individuals in CHD cohorts PMID:32396742 with overlap unclear; plus single-family reports PMID:30805980, PMID:38684296, PMID:42548218, PMID:31341187). For dismech prevalence_class: qualitative ULTRA_RARE / CASES_IN_LITERATURE.
  • Inheritance: X-linked recessive. De novo and maternally inherited variants both common. All 14 O'Rawe probands male; "All of the mutations reported here, including the duplications, are de novo or co-segregate with phenotype in affected males" (PMID:26637982 full text).
  • Penetrance: apparently complete in hemizygous males for reported pathogenic variants; incomplete in females, governed by XCI. Carrier mothers typically asymptomatic with 99:1 skewing (PMID:26637982); rare symptomatic females have extreme skewing toward the mutant X (PMID:32564284) or carry variants plus cardiac/developmental findings (Crombie review, PMID:39323550).
  • Expressivity: variable — "considerable pleiotropy and clinical variability" (PMID:31646703).
  • Anticipation / germline mosaicism / founder effects / consanguinity: none reported. (XDP's Panay founder effect belongs to the allelic disorder, not MRXS33.)
  • Carrier frequency: not established; too rare.
  • Demographics: male-predominant (M≫F); families reported from North America, Europe, Japan (PMID:30805980), China (PMID:38684296), Turkey, Brazil — no ethnic clustering.

10. Diagnostics

  • Primary modality: molecular genetic testing. Trio WES/WGS is the effective route (genotype-first identification dominates the literature: PMID:31646703; WGS + RNA-seq resolved a case where "the genome sequence data failed to implicate a candidate gene" — PMID:32714589). TAF1 is on XLID multigene panels (GTR; GenCC has PanelApp Australia submissions).
  • CMA: detects the Xq13.1 duplications (DECIPHER-class CNVs) (PMID:26637982).
  • Adjunct omics: RNA-seq of blood can reveal skewed XCI and support variant interpretation (PMID:32714589).
  • XCI studies: informative for carrier-female counseling (PMID:26637982; PMID:32564284).
  • Ancillary clinical work-up: brain MRI (CC hypoplasia, cerebellar hypoplasia), echocardiography (given 50% CHD in damaging-missense carriers — PMID:32396742), audiology, ophthalmology, EEG if seizures, swallow evaluation, spine MRI for the sacral anomaly (typically normal underlying anatomy — PMID:26637982).
  • Biomarkers: none validated for MRXS33. (Reduced RAP74 phosphorylation is a research assay — PMID:42548218.)
  • Diagnostic criteria: none published; diagnosis is molecular plus phenotype fit.
  • Differential diagnosis: Cornelia de Lange–like syndromes — "Causative variants in additional genes, such as ANKRD11, EP300, AFF4, TAF1, and BRD4, can cause a CdLS-like phenotype" (PMID:37377026; also PMID:35842780); Dubowitz syndrome phenocopies (de novo TAF1 among alternative diagnoses — PMID:33098347); other XLID syndromes (PMID:25644381); XDP in adults is clinically and mechanistically distinct.
  • Newborn/carrier screening: not performed; cascade carrier testing of mothers/female relatives after proband diagnosis.

11. Outcome / Prognosis

  • Survival: no systematic data. Missense-variant males generally survive into at least adolescence/adulthood in reported families (multigenerational pedigrees exist — five-generation family in PMID:31341187; Abidi syndrome family PMID:42548218). One death from "cardiopulmonary insufficiency" in a duplication case (PMID:26637982).
  • Morbidity/function: lifelong intellectual disability with communication impairment; ASD in a majority of the founding series; hearing loss and chronic otitis media add communication burden; CHD subset carries surgical morbidity.
  • Prognostic factors: variant class is the clearest — duplication → progressive neurodegenerative course; missense → static ID (PMID:26637982). CHD presence and severity drive early morbidity (PMID:32396742). In females, XCI ratio predicts expression (PMID:32564284).
  • Recovery potential: none for the ID; developmental gains occur with age and therapy but no formal natural-history quantification exists.
  • QoL measures: no published EQ-5D/SF-36/PROMIS data — record as a knowledge gap.

12. Treatment

No disease-modifying therapy exists; management is supportive and multidisciplinary. NCIT suggestions per dismech convention (verify reachability from NCIT:C25218):

Intervention Basis NCIT suggestion
Early developmental intervention; special education standard of care for syndromic ID Rehabilitation NCIT:C15315
Speech therapy near-universal speech delay Speech Therapy NCIT:C159273
Physical / occupational therapy hypotonia, motor delay Physical Therapy NCIT:C15302; Occupational Therapy NCIT:C121351
Feeding therapy ± gastrostomy in severe dysphagia dysphagia 11/14 Supportive Care NCIT:C15747
Hearing management: tympanostomy for chronic otitis media, hearing aids hearing impairment 10/14 Surgical Procedure NCIT:C15329 + device qualifier pattern
Strabismus management strabismus 10/14 Therapeutic Procedure NCIT:C49236
Antiseizure medication where epilepsy present seizures (PMID:31646703) Pharmacotherapy NCIT:C15986
Congenital heart defect repair CHD in 50% of damaging-missense carriers (PMID:32396742) Surgical Procedure NCIT:C15329
Genetic counseling for family X-linked recessive risk Genetic Counseling NCIT:C15240

Experimental (preclinical only). The T-type Ca²⁺ channel enhancer SAK3 in the rat Taf1-editing model: "Oral administration of SAK3 (0.25 mg/kg, p.o.) significantly rescued the behavior abnormalities in beam walking test and open field test caused by TAF1 gene editing" and "restored the excitatory post synaptic current (sEPSCs) in TAF1 edited Purkinje cells" (PMID:32622085); it also "restored the…BDNF/AKT/GSK3β signaling axis" (PMID:33359140). Evidence_source: MODEL_ORGANISM; no human trials. No MRXS33 clinical trials found on the standard registries during this research pass (worth re-checking ClinicalTrials.gov at curation time). Pharmacogenomics: none.

13. Prevention

  • Primary prevention: none possible (genetic).
  • Genetic counseling: X-linked recessive recurrence risk — 50% of sons of carrier mothers affected, 50% of daughters carriers; de novo cases carry low recurrence risk (germline mosaicism not excluded). NSGC/ACMG-standard cascade testing of maternal female relatives; XCI testing refines female risk discussion (PMID:26637982).
  • Reproductive options: prenatal diagnosis and preimplantation genetic testing once the familial variant is known (standard practice for XLID; no disease-specific guideline exists).
  • Secondary/tertiary: early echocardiogram and audiology after diagnosis to pre-empt CHD and hearing/language complications; otitis media surveillance.
  • Population screening/immunization/public health: not applicable.

14. Other Species / Natural Disease

  • Natural disease: no naturally occurring TAF1-deficiency disease is documented in companion animals or wildlife (no OMIA phene found in this research pass — verify at curation).
  • Orthologs: TAF1 is deeply conserved — mouse Taf1, rat Taf1, zebrafish taf1, Drosophila Taf1, and yeast TAF1/Bdf1 function is conserved down to fungi (yeast Bdf1/TAF1 conserved roles in homologous recombination — PMID:34056863; yeast Taf1 promoter biology — PMID:32182349). The neuron-specific microexon 34′ (N-TAF1) "incorporates the same microexon" across species (PMID:39323550).
  • Comparative note: embryonic lethality of complete loss is shared across zebrafish (PMID:31341187) and mouse (PMID:38804708), arguing for strong evolutionary constraint of the TFIID scaffold role.
  • Zoonotic potential: not applicable.

15. Model Organisms

Model System Key findings Fidelity notes
Zebrafish taf1 KO/knockdown (Gudmundsson 2019, PMID:31341187) CRISPR null + morpholino Null = embryonic lethal; "intact taf1 is essential for embryonic development"; transcriptome "enrichment for genes associated with neurodevelopmental processes"; morphant microencephaly (reduced optic tectum) rescued by human wild-type TAF1 mRNA Recapitulates microcephaly/neurodevelopmental axis; null state has no human counterpart
Zebrafish taf1/taf5 mutants (Leid 2023, PMID:37746814) CRISPR "defects…phenocopied by mutations in taf1 and taf5" — cardiac and craniofacial abnormalities via metabolic gene misregulation Supports the CHD branch; metabolism link not shown in humans
Rat Taf1 CRISPR editing (Janakiraman 2019, PMID:31344492) Postnatal intracerebroventricular CRISPR "behavioral deficits at both the neonatal and juvenile stages"; Purkinje cell hypoplasia/loss; loss of presynaptic CaV3.1; abnormal cerebellar output Regional/postnatal editing, not germline hemizygous missense — supraphysiological lesion; useful for cerebellar mechanism and SAK3 pharmacology (PMID:32622085, PMID:33359140)
Mouse Taf1 KO (Crombie 2024, PMID:38804708) Ubiquitous knockout Male null embryonic-lethal (E3.5→E9.5 window); heterozygous females: "significant increase in weight…and reduced movement" Explains absence of human null males; het female phenotype only partially parallels human carrier females
Patient-variant cell models (Hurst 2018, PMID:32714589) SH-SY5Y (WT vs TAF1 deletion vs p.Ser1600Gly) Differential expression of "neuronal ion channel genes"; "may impair neuronal differentiation and cell proliferation" IN_VITRO; neuroblastoma line, not patient iPSC-derived neurons
Patient lymphoblasts (Han 2026, PMID:42548218) LCLs with p.Met1?/p.Gln1429Pro "reduced phosphorylation of RAP74" Human-derived IN_VITRO mechanistic readout
iPSC (XDP context) (D'Ignazio 2022, PMID:35868859) Female-carrier iPSC TAF1 expression variation relevant to neostriatal vulnerability XDP, not MRXS33 — do not conflate

Resources: MGI/IMPC for Taf1 mouse alleles; ZFIN for taf1 zebrafish lines; SFARI Gene lists TAF1 as an autism candidate (gene.sfari.org).

Key Citations (PMID · first author · year · contribution)

  • 26637982 O'Rawe 2015, Am J Hum Genet — founding description, 14 males/11 families, phenotype frequencies, XCI 99:1, E-box transcriptome signature (doi:10.1016/j.ajhg.2015.11.005)
  • 31646703 Cheng 2019, Hum Mutat — +27 families; seizures, hearing loss, heart malformations, brain morphological abnormalities; pathogenicity challenges (doi:10.1002/humu.23936)
  • 32396742 Morton 2020, Circ Genom Precis Med — CHD in 50% (13/26) of damaging missense carriers
  • 39323550 Crombie 2024, R Soc Open Sci — comprehensive TAF1 review; retracted enzymatic-activity literature flagged (doi:10.1098/rsos.240790)
  • 38804708 Crombie 2024, Dis Model Mech — Taf1 KO mouse; male embryonic lethality
  • 31341187 Gudmundsson 2019, Sci Rep — zebrafish knockout; human mRNA rescue
  • 37746814 Leid 2023, Biol Open — zebrafish taf1/taf5 cardiac/craniofacial phenocopy
  • 31344492 / 32622085 / 33359140 Janakiraman 2019/2020, Dhanalakshmi 2021, Neurobiol Dis — rat model; Purkinje/CaV3.1; SAK3 rescue; BDNF/AKT/GSK3β
  • 32714589 Hurst 2018, Neuronal Signal — p.Ser1600Gly; WGS+RNA-seq diagnostics; ion-channel gene dysregulation
  • 42548218 Han 2026, Am J Med Genet A — Abidi syndrome is TAF1-related; reduced RAP74 phosphorylation
  • 32564284 Vianna 2020, Mol Neurobiol — affected females via extreme XCI skewing
  • 30805980 Okamoto 2020 · 38684296 Li 2024 · 25644381 Hu 2016 — additional families/cohorts
  • 37377026 Kaur 2023 · 35842780 Coursimault 2022 · 33098347 Dyment 2021 — CdLS-like/Dubowitz differential diagnosis
  • 29229810 Bragg 2017, PNAS — XDP SVA hexameric repeat (allelic disorder context)
  • 36958711 Leigh 2023, BBA Mol Basis Dis — TAF1 bromodomain inhibition and CHD epigenetics

Curation caveats for this report: (1) all snippets above must be re-verified against references_cache after just fetch-reference — several were extracted through an intermediary summarization step; (2) variant residue numbering differs between O'Rawe 2015 and ClinVar NM_004606.5 records; (3) all suggested HP/GO/CL/UBERON/NCIT IDs require OLS verification; (4) the modified references_cache/DOI_10.1172_jci152297.md in this worktree is a TAB2 cardiomyopathy paper unrelated to this disease.

Sources: - OMIM #300966 — MRXS33 - ClinVar RCV000203524 — TAF1 p.Ile1317Thr - ClinVar RCV000203515 — TAF1 p.Arg1226Trp - ClinVar RCV001027762 — TAF1 p.Lys1556Glu - GTR condition C4225418 - GenCC — TAF1 / MRXS33 (PanelApp Australia) - NORD MONDO disease page - Crombie 2024 review — Royal Society Open Science - O'Rawe 2015 — PMC4678794 - Morton 2020 — PMC7329268 - Hurst 2018 — PMC7373232 - Gudmundsson 2019 — Scientific Reports - SFARI Gene — TAF1

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 32
Resolved 32
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 32
On topic 22
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 55
Resolved 54
Unresolved (possible confabulation) 0
Obsolete 0
Unverifiable 1
Terms whose name was checked 17
Terms named correctly 3
Terms named as a different term 12
Terms whose name is worth a second look 2

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • HP:0001263 (1 mention) - the report calls it "infancy; static → ID"; HP calls it Global developmental delay
  • HP:0001249 (1 mention) - the report calls it "childhood; lifelong, largely stable"; HP calls it Intellectual disability
  • HP:0000750 (1 mention) - the report calls it "early childhood"; HP calls it Delayed speech and language development
  • HP:0002079 (1 mention) - the report calls it "congenital"; HP calls it Hypoplasia of the corpus callosum
  • HP:0000365 (1 mention) - the report calls it "childhood"; HP calls it Hearing impairment
  • HP:0000486 (1 mention) - the report calls it "childhood"; HP calls it Strabismus
  • HP:0000252 (1 mention) - the report calls it "congenital/postnatal"; HP calls it Microcephaly
  • HP:0001382 (1 mention) - the report calls it "childhood"; HP calls it Joint hypermobility
  • HP:0000729 (1 mention) - the report calls it "childhood"; HP calls it Autistic behavior
  • HP:0000389 (1 mention) - the report calls it "childhood, recurrent"; HP calls it Chronic otitis media
  • HP:0001250 (1 mention) - the report calls it "variable"; HP calls it Seizure
  • HP:0001321 (1 mention) - the report calls it "congenital"; HP calls it Cerebellar hypoplasia

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

  • UBERON:0000955 (1 mention) - the report calls it "Primary: brain"; UBERON calls it brain**
  • UBERON:0000948 (1 mention) - the report calls it "Cardiac: heart"; UBERON calls it heart**, and lists "chambered heart" among its other names